[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 1046
1. Dulucq JL, Wintringer P, Stabilini C, Mahajna A: Laparoscopic rectal resection with anal sphincter preservation for rectal cancer: long-term outcome. Surg Endosc; 2005 Nov;19(11):1468-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic rectal resection with anal sphincter preservation for rectal cancer: long-term outcome.
  • BACKGROUND: Total mesorectal excision (TME) is the surgical gold standard treatment for middle and low third rectal carcinoma.
  • The purposes of this study were to examine prospectively our experience with laparoscopic TME and high rectal resections, to evaluate the surgical outcomes and oncologic adequacy, and to discuss the role of this procedure in the treatment of rectal cancer.
  • METHODS: Between December 1992 and December 2004, all patients who underwent elective laparoscopic sphincter preserving rectal resection for rectal cancer were enrolled prospectively in this study.
  • CONCLUSION: Laparoscopic anterior resection and TME with anal sphincter preservation for rectal cancer is feasible and safe.
  • [MeSH-major] Laparoscopy. Rectal Neoplasms / surgery

  • Genetic Alliance. consumer health - Anal Cancer.
  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] CA Cancer J Clin. 1998 Jan-Feb;48(1):6-29 [9449931.001]
  • [Cites] Ann Surg. 1979 Sep;190(3):350-60 [485609.001]
  • [Cites] Br J Surg. 2003 Aug;90(8):999-1003 [12905555.001]
  • [Cites] Surg Endosc. 2004 Oct;18(10):1457-62 [15791369.001]
  • [Cites] Dis Colon Rectum. 1997 Jul;40(7):747-51 [9221846.001]
  • [Cites] Arch Surg. 1998 Aug;133(8):894-9 [9711965.001]
  • [Cites] N Engl J Med. 2001 Aug 30;345(9):638-46 [11547717.001]
  • [Cites] Br J Surg. 1982 Oct;69(10):613-6 [6751457.001]
  • [Cites] J Am Coll Surg. 1995 Oct;181(4):335-46 [7551328.001]
  • [Cites] World J Surg. 1992 Sep-Oct;16(5):848-57 [1462619.001]
  • [Cites] Lancet. 2004 Apr 10;363(9416):1187-92 [15081650.001]
  • [Cites] JAMA. 2002 Jan 16;287(3):321-8 [11790211.001]
  • [Cites] Surg Endosc. 1998 Sep;12(9):1131-6 [9716766.001]
  • [Cites] Eur J Surg Oncol. 1999 Aug;25(4):368-74 [10419706.001]
  • [Cites] Ann Surg. 2003 Mar;237(3):335-42 [12616116.001]
  • [Cites] Chirurg. 1998 Aug;69(8):846-53 [9782401.001]
  • [Cites] Br J Surg. 1982 Jun;69(6):301-4 [7082951.001]
  • [Cites] Lancet Oncol. 2003 Nov;4(11):695-702 [14602250.001]
  • [Cites] Surg Endosc. 2002 Sep;16(9):1320-3 [11984674.001]
  • [Cites] Lancet. 2002 Jun 29;359(9325):2224-9 [12103285.001]
  • [Cites] Surg Endosc. 1995 Oct;9(10):1101-5 [8553212.001]
  • [Cites] Dis Colon Rectum. 1996 Oct;39(10 Suppl):S35-46 [8831545.001]
  • [Cites] Dis Colon Rectum. 2001 May;44(5):638-46 [11357021.001]
  • [Cites] Surg Gynecol Obstet. 1990 Jun;170(6):517-21 [1693016.001]
  • [Cites] Dis Colon Rectum. 2000 Jan;43(1):1-8 [10813116.001]
  • [Cites] Dis Colon Rectum. 2001 Mar;44(3):315-21 [11289275.001]
  • [Cites] World J Surg. 1999 Aug;23(8):816-24 [10415208.001]
  • [Cites] Surg Endosc. 1999 Jun;13(6):567-71 [10347292.001]
  • [Cites] Surg Endosc. 2004 Feb;18(2):281-9 [14691716.001]
  • [Cites] Dis Colon Rectum. 1995 May;38(5):480-6; discussion 486-7 [7736878.001]
  • [Cites] Surg Endosc. 2002 Jun;16(6):949-53 [12163961.001]
  • [Cites] Br J Surg. 1998 Apr;85(4):526-9 [9607540.001]
  • (PMID = 16222464.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


2. Prall F, Wöhlke M, Klautke G, Schiffmann L, Fietkau R, Barten M: Tumour regression and mesorectal lymph node changes after intensified neoadjuvant chemoradiation for carcinoma of the rectum. APMIS; 2006 Mar;114(3):201-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tumour regression and mesorectal lymph node changes after intensified neoadjuvant chemoradiation for carcinoma of the rectum.
  • Neoadjuvant radiation or chemoradiation is currently the treatment of choice for patients with locally advanced carcinoma of the rectum.
  • [MeSH-major] Lymph Nodes / pathology. Neoadjuvant Therapy. Rectal Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / drug therapy. Adenocarcinoma / pathology. Adenocarcinoma / radiotherapy. Antigens, CD / metabolism. Antimetabolites, Antineoplastic / pharmacology. Antineoplastic Agents, Phytogenic / pharmacology. Camptothecin / analogs & derivatives. Camptothecin / pharmacology. Capecitabine. Dendritic Cells / metabolism. Deoxycytidine / analogs & derivatives. Deoxycytidine / pharmacology. Female. Fluorouracil / pharmacology. Humans. Immunoglobulins / metabolism. Male. Membrane Glycoproteins / metabolism. Middle Aged

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16643187.001).
  • [ISSN] 0903-4641
  • [Journal-full-title] APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
  • [ISO-abbreviation] APMIS
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antimetabolites, Antineoplastic; 0 / Antineoplastic Agents, Phytogenic; 0 / CD83 antigen; 0 / Immunoglobulins; 0 / Membrane Glycoproteins; 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; 7673326042 / irinotecan; U3P01618RT / Fluorouracil; XT3Z54Z28A / Camptothecin
  •  go-up   go-down


3. Tsamandas AC, Kardamakis D, Petsas T, Zolota V, Vassiliou V, Matatsoris T, Kalofonos H, Vagianos CE, Scopa CD: Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome. In Vivo; 2007 Jan-Feb;21(1):113-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome.
  • This study examined the bcl-2, bax and p53 expression in rectal adenocarcinomas and their relationship with tumor prognosis.
  • PATIENTS AND METHODS: Paraffin-embedded 4-microm tumor sections obtained from patients with rectal adenocarcinoma who underwent colectomy for therapeutic reasons, were analyzed with a standard streptavidin biotin peroxidase method, using polyclonal and monoclonal antibodies.
  • CONCLUSION: In rectal adenocarcinoma, bax and bcl-2 proteins co-express frequently with p53.
  • [MeSH-major] Adenocarcinoma / pathology. Proto-Oncogene Proteins c-bcl-2 / metabolism. Rectal Neoplasms / pathology. Tumor Suppressor Protein p53 / metabolism. bcl-2-Associated X Protein / metabolism
  • [MeSH-minor] Adult. Aged. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Prognosis. Survival Rate

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] In Vivo. 2007 May-Jun;21(3):553. Zolota, V [added]; Vassiliou, V [added]; Matatsoris, T [added]
  • [ErratumIn] In Vivo. 2007 Nov-Dec;21(6):1172
  • (PMID = 17354623.001).
  • [ISSN] 0258-851X
  • [Journal-full-title] In vivo (Athens, Greece)
  • [ISO-abbreviation] In Vivo
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Proto-Oncogene Proteins c-bcl-2; 0 / Tumor Suppressor Protein p53; 0 / bcl-2-Associated X Protein
  •  go-up   go-down


Advertisement
4. Marín García D, Cárdenas Lafuente F, Utrilla Ayala Mdel C, Galán Jurado MV, Jiménez Martín JJ, García Ordóñez MA: [Primary diffuse large B-cell lymphoma of the rectum simulating a rectal adenocarcinoma]. Gastroenterol Hepatol; 2010 Feb;33(2):92-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Primary diffuse large B-cell lymphoma of the rectum simulating a rectal adenocarcinoma].
  • [Transliterated title] Linfoma de tipo B difuso de células grandes primario rectal que simula un adenocarcinoma de recto.
  • Dawson's criteria are highly useful in the differential diagnosis between primary colorectal involvement and gastrointestinal tract involvement secondary to systemic lymphoma, which is important due to the distinct prognosis and treatment of these entities.
  • [MeSH-major] Adenocarcinoma / diagnosis. Lymphoma, Large B-Cell, Diffuse / diagnosis. Rectal Neoplasms / diagnosis
  • [MeSH-minor] Aged. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Colonoscopy. Cyclophosphamide / therapeutic use. Diagnosis, Differential. Doxorubicin / therapeutic use. Humans. Immunohistochemistry. Male. Meta-Analysis as Topic. Middle Aged. Neoplasm Staging. Prednisone / therapeutic use. Prognosis. Radiography, Abdominal. Rectum / pathology. Tomography, X-Ray Computed. Vincristine / therapeutic use

  • Genetic Alliance. consumer health - Large B cell diffuse lymphoma.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 Elsevier España, S.L. All rights reserved.
  • (PMID = 19875198.001).
  • [ISSN] 0210-5705
  • [Journal-full-title] Gastroenterología y hepatología
  • [ISO-abbreviation] Gastroenterol Hepatol
  • [Language] spa
  • [Publication-type] Case Reports; Comparative Study; English Abstract; Journal Article
  • [Publication-country] Spain
  • [Chemical-registry-number] 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
  •  go-up   go-down


5. Wang Y, Cummings B, Catton P, Dawson L, Kim J, Ringash J, Wong R, Yi QL, Brierley J: Primary radical external beam radiotherapy of rectal adenocarcinoma: long term outcome of 271 patients. Radiother Oncol; 2005 Nov;77(2):126-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary radical external beam radiotherapy of rectal adenocarcinoma: long term outcome of 271 patients.
  • BACKGROUND AND PURPOSE: To assess local control, survival and toxicity following primary radical external beam radiotherapy of rectal adenocarcinoma treated between 1978 and 1997, and to compare practices and outcomes between the two decades of study.
  • For patients with mobile, partially fixed and fixed tumors, overall 5 year survival was 48, 26 and 6%, respectively, and cancer specific 5 year survival was 59, 33 and 9%, respectively.
  • CONCLUSIONS: Radical external beam radiotherapy is a reasonable treatment option for rectal carcinoma for patients who are not surgical candidates or refuse surgery.
  • [MeSH-major] Adenocarcinoma / mortality. Adenocarcinoma / radiotherapy. Radiotherapy, High-Energy / methods. Rectal Neoplasms / mortality. Rectal Neoplasms / radiotherapy
  • [MeSH-minor] Aged. Biopsy, Needle. Chi-Square Distribution. Dose-Response Relationship, Radiation. Female. Follow-Up Studies. Humans. Immunohistochemistry. Logistic Models. Male. Middle Aged. Neoplasm Staging. Probability. Radiation Dosage. Retrospective Studies. Risk Assessment. Survival Analysis. Time Factors. Treatment Outcome

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16216364.001).
  • [ISSN] 0167-8140
  • [Journal-full-title] Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • [ISO-abbreviation] Radiother Oncol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


6. Skalický T, Treska V, Spidlen V, Vodicka V, Sutnar A, Liska V, Klecka J, Simánek V, Safránek J, Fichtl J, Polák M: [Surgical treatment of liver and pulmonary metastases of colorectal carcinoma]. Rozhl Chir; 2010 Apr;89(4):253-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Surgical treatment of liver and pulmonary metastases of colorectal carcinoma].
  • THE AIM: The aim of the work was to evaluate the set of 10 patients, who were operated on hepatic and pulmonary metastases of colorectal carcinoma at the Surgical Clinic of Medical Faculty of Charles University and Faculty Hospital in Plzeń in years from 2005 till 2009.
  • THE SET OF THE PATIENTS: In years from 2005 till 12/2009 we operated 10 patients during whose affection there occurred hepatic and pulmonary metastases of colorectal carcinoma and these were solved surgically.
  • In 10% it was hepatic resection in the first period after the operation of primary carcinoma, it was the first performance on the hepatic parenchyma in 90%.
  • In 4 cases primary carcinoma was in the rectum and in 6 cases in the large intestine.
  • Rectal carcinoma spread into lungs in 50%.
  • An average time of a 5-year survival in the patients after resection of hepatic and pulmonary metastases of colorectal carcinoma was 26%.
  • THE CONCLUSION: Hepatic and pulmonary resection in the selected patients with generalized colorectal carcinoma extends the period of a survival and does not worsen the quality of the life.
  • [MeSH-major] Carcinoma / secondary. Carcinoma / surgery. Colorectal Neoplasms / pathology. Liver Neoplasms / secondary. Liver Neoplasms / surgery. Lung Neoplasms / secondary. Lung Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20586164.001).
  • [ISSN] 0035-9351
  • [Journal-full-title] Rozhledy v chirurgii : měsíčník Československé chirurgické společnosti
  • [ISO-abbreviation] Rozhl Chir
  • [Language] cze
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Czech Republic
  •  go-up   go-down


7. Rouanet P: [Preoperative treatment impact for ultralow rectal carcinoma sphincter preservation]. Cancer Radiother; 2006 Nov;10(6-7):451-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Preoperative treatment impact for ultralow rectal carcinoma sphincter preservation].
  • [Transliterated title] Impact des traitements préopératoires (radiothérapie et chimiothérapie) dans la conservation sphinctérienne des cancers du très bas rectum.
  • Sphincter preservation for low rectal carcinoma must be evaluated with a plurifactoriel approach.
  • [MeSH-major] Limb Salvage. Reconstructive Surgical Procedures / methods. Rectum

  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17005428.001).
  • [ISSN] 1278-3218
  • [Journal-full-title] Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
  • [ISO-abbreviation] Cancer Radiother
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 23
  •  go-up   go-down


8. Kuwabara M, Wada K, Maeda Y, Miyazaki A, Tsunemitsu H: First isolation of cytopathogenic bovine torovirus in cell culture from a calf with diarrhea. Clin Vaccine Immunol; 2007 Aug;14(8):998-1004
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A cytopathogenic virus (designated the Aichi/2004 strain) was isolated in a human rectal adenocarcinoma cell line (HRT-18) from the ileum contents of a calf with diarrhea.

  • MedlinePlus Health Information. consumer health - Diarrhea.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Vet Res. 2002 Mar;63(3):342-8 [11911568.001]
  • [Cites] Virus Res. 2006 Jan;115(1):56-68 [16137782.001]
  • [Cites] J Vet Diagn Invest. 2003 May;15(3):205-12 [12735342.001]
  • [Cites] J Virol. 2003 Sep;77(17):9567-77 [12915570.001]
  • [Cites] Brief Bioinform. 2004 Jun;5(2):150-63 [15260895.001]
  • [Cites] J Natl Cancer Inst. 1974 Apr;52(4):1101-10 [4826581.001]
  • [Cites] Vet Microbiol. 1982 Jul;7(3):221-40 [7051518.001]
  • [Cites] J Gen Virol. 1983 Sep;64 (Pt 9):1849-58 [6886677.001]
  • [Cites] J Clin Microbiol. 1984 May;19(5):623-30 [6429189.001]
  • [Cites] Vet Pathol. 1984 Jul;21(4):407-17 [6431684.001]
  • [Cites] Vet Microbiol. 1984 Oct;9(6):523-31 [6506447.001]
  • [Cites] Am J Vet Res. 1985 May;46(5):1003-10 [2408519.001]
  • [Cites] J Gen Virol. 1986 Jul;67 ( Pt 7):1305-14 [3723110.001]
  • [Cites] J Med Virol. 1986 Sep;20(1):67-78 [3093635.001]
  • [Cites] J Clin Microbiol. 1987 Apr;25(4):637-40 [3571473.001]
  • [Cites] Mol Biol Evol. 1987 Jul;4(4):406-25 [3447015.001]
  • [Cites] Vet Microbiol. 1989 Mar;19(3):233-43 [2718353.001]
  • [Cites] J Clin Microbiol. 1990 Feb;28(2):201-6 [2107200.001]
  • [Cites] J Clin Microbiol. 1990 Jun;28(6):1454-7 [2166085.001]
  • [Cites] J Vet Med Sci. 1991 Jun;53(3):433-7 [1653037.001]
  • [Cites] Am J Vet Res. 1991 Nov;52(11):1769-73 [1664668.001]
  • [Cites] Adv Virus Res. 1994;43:233-73 [8191955.001]
  • [Cites] Arch Virol. 1994;136(3-4):309-23 [8031236.001]
  • [Cites] Nucleic Acids Res. 1994 Nov 11;22(22):4673-80 [7984417.001]
  • [Cites] J Virol Methods. 1997 Jul;66(2):303-9 [9255741.001]
  • [Cites] J Virol Methods. 1997 Dec;69(1-2):191-5 [9504764.001]
  • [Cites] J Virol. 1998 May;72(5):3507-11 [9557628.001]
  • [Cites] J Clin Microbiol. 1998 May;36(5):1266-70 [9574689.001]
  • [Cites] J Infect Dis. 1998 Nov;178(5):1263-9 [9780245.001]
  • [Cites] Arch Virol. 1999;144(1):167-75 [10076517.001]
  • [Cites] Virus Res. 1999 Nov;64(2):137-49 [10518710.001]
  • [Cites] Acta Paediatr. 2005 Aug;94(8):1085-8 [16188853.001]
  • [Cites] Am J Vet Res. 2003 Apr;64(4):485-90 [12693541.001]
  • (PMID = 17567770.001).
  • [ISSN] 1556-6811
  • [Journal-full-title] Clinical and vaccine immunology : CVI
  • [ISO-abbreviation] Clin. Vaccine Immunol.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ AB285125/ AB285126/ AB285127
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Viral; 0 / DNA, Viral; 0 / Viral Proteins
  • [Other-IDs] NLM/ PMC2044491
  •  go-up   go-down


9. Saad RS, Silverman JF, Khalifa MA, Rowsell C: CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma. Appl Immunohistochem Mol Morphol; 2009 May;17(3):196-201
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma.
  • There are limited data regarding CDX2 expression in rectal carcinoma.
  • The CK20/CK7 immunoprofile of colorectal adenocarcinoma has been described in studies, which have mostly lumped colonic and rectal tumors together.
  • In this study, we investigated the diagnostic utility of immunohistochemical stains for CK7, CK20, and CDX2 in a series of rectal adenocarcinoma.
  • Fifty-five specimens of rectal adenocarcinomas were retrieved and immunostained for CK7 (Dako-M7018), CK20 (NovoCastra NCL-L-CK20), and CDX2 (NovoCastra NCL-CDX2).
  • Thirty cases of pancreatic adenocarcinoma and 15 cholangiocarcinomas were also studied as a comparison group.
  • CK7 was expressed in 12/55 (22%) and CK20 in 48/55 (87%) cases of rectal adenocarcinoma.
  • The CK7-/CK20+ immunophenotype was identified in 36/55 (65%), CK7+/CK20+ in 12/55 (22%), and CK7-/CK20- in 7/55 (13%) rectal adenocarcinoma.
  • Benign rectal mucosa was available in 37 cases and showed the following results: CK7-/CK20+ in 25/37 (67%), CK7+/CK20+ in 8/37 (22%) and CK7-/CK20- in 4/37 (11%) cases.
  • In conclusion, CK7 can be expressed in rectal adenocarcinoma, and should not be used as the sole basis for excluding a rectal primary.
  • CDX2 is a sensitive marker for rectal origin of adenocarcinoma.
  • It can be helpful in cases with metastatic rectal carcinoma, especially those with CK7+/CK20+ or CK20-/CK7- immunophenotype.
  • In this study, CDX2 expression was not influenced by the grade (differentiation) of rectal adenocarcinoma.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Appl Immunohistochem Mol Morphol. 2009 Oct;17(5):464
  • (PMID = 19098678.001).
  • [ISSN] 1533-4058
  • [Journal-full-title] Applied immunohistochemistry & molecular morphology : AIMM
  • [ISO-abbreviation] Appl. Immunohistochem. Mol. Morphol.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CDX2 protein, human; 0 / Homeodomain Proteins; 0 / Keratin-20; 0 / Keratin-7
  •  go-up   go-down


10. Göhl J, Hohenberger W, Merkel S: Lymph node dissection in rectal carcinoma: TME and what else? Onkologie; 2009 Feb;32(1-2):57-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lymph node dissection in rectal carcinoma: TME and what else?
  • Total mesorectal excision (TME) has been established as a standardized radical surgical procedure in malignant tumors of the middle and lower rectal third.
  • In carcinomas of the upper rectal third, TME is seen as controversial.
  • Total mesorectal excision in the radical surgical treatment of lower and middle third rectal carcinomas is the essential part of lymphatic dissection in these tumors.
  • [MeSH-major] Digestive System Surgical Procedures / methods. Lymph Node Excision / methods. Rectal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2009 S. Karger AG, Basel.
  • (PMID = 19209023.001).
  • [ISSN] 1423-0240
  • [Journal-full-title] Onkologie
  • [ISO-abbreviation] Onkologie
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  • [Number-of-references] 44
  •  go-up   go-down


11. Nahas CS, Shia J, Joseph R, Schrag D, Minsky BD, Weiser MR, Guillem JG, Paty PB, Klimstra DS, Tang LH, Wong WD, Temple LK: Squamous-cell carcinoma of the rectum: a rare but curable tumor. Dis Colon Rectum; 2007 Sep;50(9):1393-400
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Squamous-cell carcinoma of the rectum: a rare but curable tumor.
  • PURPOSE: This study was designed to evaluate one institution's experience with treatment outcomes for rectal squamous-cell carcinoma.
  • METHODS: Using our prospective Colorectal Database, we identified patients diagnosed with rectal squamous-cell carcinoma at our institution between 1983 and 2005.
  • Pathology was rereviewed, tumor immunophenotype was compared to control cases of anal squamous-cell carcinoma and rectal adenocarcinoma, treatment modalities and outcomes were analyzed.
  • Immunophenotypical analysis showed similar keratin expression profile between rectal squamous-cell carcinoma (n = 5) and rectal adenocarcinoma (n = 5), which is different from anal squamous-cell carcinoma (n = 10).
  • Immunohistochemistry suggests a common cellular origin for rectal squamous-cell carcinoma and rectal adenocarcinoma, which is different from anal squamous-cell carcinoma.
  • [MeSH-major] Antimetabolites, Antineoplastic / therapeutic use. Carcinoma, Squamous Cell / therapy. Colectomy. Fluorouracil / therapeutic use. Rectal Neoplasms / therapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / metabolism. Female. Follow-Up Studies. Humans. Immunohistochemistry. Keratins / metabolism. Male. Middle Aged. Neoplasm Staging. Prospective Studies. Radiotherapy, Adjuvant. Survival Rate. Treatment Outcome. United States / epidemiology

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17661147.001).
  • [ISSN] 0012-3706
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Biomarkers, Tumor; 68238-35-7 / Keratins; U3P01618RT / Fluorouracil
  •  go-up   go-down


12. Kurt M, Ozkan L, Kurt E, Cetintas SK, Aygun S, Ercan I, Yilmazlar T, Memik F: Comparison of protracted infusion 5-fluorouracil and capecitabine in adjuvant chemoradiotherapy for rectal cancer. Hepatogastroenterology; 2008 Jul-Aug;55(85):1158-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparison of protracted infusion 5-fluorouracil and capecitabine in adjuvant chemoradiotherapy for rectal cancer.
  • BACKGROUND/AIMS: 5-Fluorouracil-based chemoradiotherapy is the most widely used treatment modality in the adjuvant treatment of rectal cancer.
  • METHODOLOGY: Patients with stage II and stage III rectal adenocarcinoma, who were included in this analysis, received adjuvant chemoradiotherapy consisting of external-beam radiotherapy (50.4-54Gy) either with 5-Fluorouracil at a median dose of 300 mg/m2/day by protracted venous infusion for 5 days a week, or capecitabine at a median dose of 1650 mg/m2/day for 5 days a week after surgery.
  • CONCLUSIONS: Capecitabine is at least as effective as 5-Fluorouracil in the postoperative treatment of rectal adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / therapy. Antimetabolites, Antineoplastic / administration & dosage. Deoxycytidine / analogs & derivatives. Fluorouracil / administration & dosage. Fluorouracil / analogs & derivatives. Rectal Neoplasms / therapy

  • Genetic Alliance. consumer health - Rectal Cancer.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18795649.001).
  • [ISSN] 0172-6390
  • [Journal-full-title] Hepato-gastroenterology
  • [ISO-abbreviation] Hepatogastroenterology
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; U3P01618RT / Fluorouracil
  •  go-up   go-down


13. Matsuoka H, Nakamura A, Masaki T, Sugiyama M, Nitatori T, Ohkura Y, Sakamoto A, Atomi Y: Optimal diagnostic criteria for lateral pelvic lymph node metastasis in rectal carcinoma. Anticancer Res; 2007 Sep-Oct;27(5B):3529-33
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Optimal diagnostic criteria for lateral pelvic lymph node metastasis in rectal carcinoma.
  • AIM: The purpose of this study was to determine the optimal diagnostic criteria for lateral pelvic lymph node metastasis in patients with rectal carcinoma.
  • PATIENTS AND METHODS: From July 1997 to June 2005, fifty-one patients with locally advanced middle or lower rectal carcinoma underwent preoperative MRI examination, followed by total mesorectal excision with lateral pelvic node dissection.
  • CONCLUSION: An ovoid shape with a transverse axis diameter of 5 mm or larger on MRI was considered as the optimal criterion for diagnosing lateral lymph node metastasis in patients with rectal carcinoma.
  • [MeSH-major] Lymph Nodes / pathology. Pelvic Neoplasms / pathology. Rectal Neoplasms / diagnosis. Rectal Neoplasms / secondary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17972513.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  •  go-up   go-down


14. Vagliasindi A, Teodorani N, Palazzi S, Mura G, Framarini M, Mazza P, Datiti A, Rosetti P, Curcio A, Verdecchia GM: [Neoadjuvant radiochemotherapy of rectal carcinoma: retrospective analysis of a personal experience]. Suppl Tumori; 2005 May-Jun;4(3):S24-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Neoadjuvant radiochemotherapy of rectal carcinoma: retrospective analysis of a personal experience].
  • [Transliterated title] Radiochemioterapia neoadiuvante nel carcinoma del retto analisi retrospettiva di un'esperienza personale.
  • Even if surgical resection continues to be the mainstay of treatment in rectal cancer, preoperative chemoradiation may downstage locally advanced rectal cancer, in some cases with no residual tumors.
  • Compared with surgery alone, preoperative radiotherapy and chemotherapy improves outcomes in patients with locally advanced rectal cancer.
  • In the present review we summarize the results of preoperative chemoradiation therapy in a group of 15 patients who underwent surgical resection with total mesorectal excision (TME) for advanced mid and low rectal cancer from February 2002 to February 2004.
  • [MeSH-major] Rectal Neoplasms / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16437881.001).
  • [ISSN] 2283-5423
  • [Journal-full-title] I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.]
  • [ISO-abbreviation] Suppl Tumori
  • [Language] ita
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


15. Zhang XM, Yu D, Zhang HL, Dai Y, Bi D, Liu Z, Prince MR, Li C: 3D dynamic contrast-enhanced MRI of rectal carcinoma at 3T: correlation with microvascular density and vascular endothelial growth factor markers of tumor angiogenesis. J Magn Reson Imaging; 2008 Jun;27(6):1309-16
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] 3D dynamic contrast-enhanced MRI of rectal carcinoma at 3T: correlation with microvascular density and vascular endothelial growth factor markers of tumor angiogenesis.
  • PURPOSE: To determine how dynamic contrast-enhanced (DCE) MRI at 3T correlates with rectal carcinoma angiogenesis.
  • MATERIALS AND METHODS: Three-dimensional (3D) DCE MRI was performed in 38 patients (23 males, 15 females, mean age 60 years) with histologically-confirmed rectal carcinoma at 3T.
  • Time-intensity curves (TICs) were used to measure peak enhancement ratio (ER(peak)), time to peak enhancement (T(peak)), first enhancement time (T(first-enhance)), and uptake rate for rectal tumor, normal rectal wall, and gluteal muscle.
  • RESULTS: Rectal carcinoma showed higher ER(peak) (3.0 +/- 0.9 vs. 1.9 +/- 0.9, P < 0.001), higher uptake rate (2.8 +/- 1.5/minute vs. 1.2 +/- 0.9/minute, P < 0.001), earlier T(peak) (88 +/- 56 seconds vs. 124 +/- 72 seconds, P = 0.027), and earlier T(first-enhance) (34 +/- 6 seconds vs. 40 +/- 7 seconds, P = 0.008) than normal rectal wall.
  • Adenocarcinoma had shorter T(peak) compared to signet cell carcinoma (77 +/- 48 seconds vs. 160 +/- 62 seconds, P = 0.004).
  • CONCLUSION: DCE MRI parameters help predict rectal tumor angiogenesis measured by MVD and VEGF expression and discriminate malignant from normal tissue.
  • [MeSH-major] Adenocarcinoma / blood supply. Carcinoma, Signet Ring Cell / blood supply. Contrast Media / administration & dosage. Imaging, Three-Dimensional / methods. Magnetic Resonance Imaging / methods. Neovascularization, Pathologic / diagnosis. Rectal Neoplasms / blood supply
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers / metabolism. Female. Gadolinium DTPA. Humans. Image Enhancement / methods. Magnetics. Male. Middle Aged. Rectum / blood supply. Rectum / pathology. Vascular Endothelial Growth Factor A / metabolism

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2008 Wiley-Liss, Inc
  • (PMID = 18504761.001).
  • [ISSN] 1053-1807
  • [Journal-full-title] Journal of magnetic resonance imaging : JMRI
  • [ISO-abbreviation] J Magn Reson Imaging
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Contrast Media; 0 / Vascular Endothelial Growth Factor A; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


16. Vuong T, Devic S, Moftah B, Evans M, Podgorsak EB: High-dose-rate endorectal brachytherapy in the treatment of locally advanced rectal carcinoma: technical aspects. Brachytherapy; 2005;4(3):230-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High-dose-rate endorectal brachytherapy in the treatment of locally advanced rectal carcinoma: technical aspects.
  • PURPOSE: In this era of new radiation technologies and tumor imaging, a high-dose-rate endorectal brachytherapy has been developed and tested in a phase I/II study of advanced rectal tumors.
  • Patients with resectable rectal cancer (staged T2, T3, or early T4) were treated with preoperative high-dose-rate endorectal brachytherapy followed by surgery 6-8 weeks later.
  • The use of a multichannel flexible endorectal applicator leads to tumor downstaging before surgery in patients with resectable locally advanced rectal carcinomas.
  • [MeSH-major] Brachytherapy / instrumentation. Brachytherapy / methods. Radiotherapy Planning, Computer-Assisted / methods. Rectal Neoplasms / radiography. Rectal Neoplasms / radiotherapy

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16182224.001).
  • [ISSN] 1538-4721
  • [Journal-full-title] Brachytherapy
  • [ISO-abbreviation] Brachytherapy
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Hermanek P, Junginger T: The circumferential resection margin in rectal carcinoma surgery. Tech Coloproctol; 2005 Dec;9(3):193-9; discussion 199-200
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The circumferential resection margin in rectal carcinoma surgery.
  • After radical resection of rectal carcinoma, the circumferential resection margin (CRM) on the non-peritonealized surface of the resected specimen is of critical importance.
  • [MeSH-major] Colectomy / methods. Neoplasm Invasiveness / pathology. Neoplasm Recurrence, Local / pathology. Rectal Neoplasms / pathology. Rectal Neoplasms / surgery
  • [MeSH-minor] Biopsy, Needle. Colonoscopy / methods. Female. Humans. Immunohistochemistry. Magnetic Resonance Imaging. Male. Neoadjuvant Therapy / methods. Neoplasm Staging. Predictive Value of Tests. Preoperative Care. Prognosis. Risk Assessment. Sensitivity and Specificity. Survival Analysis. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16328130.001).
  • [ISSN] 1123-6337
  • [Journal-full-title] Techniques in coloproctology
  • [ISO-abbreviation] Tech Coloproctol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Review
  • [Publication-country] Italy
  • [Number-of-references] 14
  •  go-up   go-down


18. Koukourakis MI, Simopoulos C, Pitiakoudis M, Lyratzopoulos N, Romanidis K, Giatromanolaki A, Polychronidis A, Kouklakis G, Sivridis E, Minopoulos G, Manolas K: Hypofractionated accelerated radiotherapy, cytoprotection and capecitabine in the treatment of rectal cancer: a feasibility study. Anticancer Res; 2008 Sep-Oct;28(5B):3035-40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hypofractionated accelerated radiotherapy, cytoprotection and capecitabine in the treatment of rectal cancer: a feasibility study.
  • BACKGROUND: This is a report on the feasibility and efficacy of hypofractionated accelerated radiotherapy combined with amifostine cytoprotection (hypoARC) and capecitabine in the treatment of rectal adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / therapy. Amifostine / therapeutic use. Antimetabolites, Antineoplastic / therapeutic use. Deoxycytidine / analogs & derivatives. Fluorouracil / analogs & derivatives. Radiation-Protective Agents / therapeutic use. Rectal Neoplasms / therapy

  • Genetic Alliance. consumer health - Rectal Cancer.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • Hazardous Substances Data Bank. AMIFOSTINE .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19031952.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Radiation-Protective Agents; 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; M487QF2F4V / Amifostine; U3P01618RT / Fluorouracil
  •  go-up   go-down


19. Agha A, Fürst A, Hierl J, Iesalnieks I, Glockzin G, Anthuber M, Jauch KW, Schlitt HJ: Laparoscopic surgery for rectal cancer: oncological results and clinical outcome of 225 patients. Surg Endosc; 2008 Oct;22(10):2229-37
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic surgery for rectal cancer: oncological results and clinical outcome of 225 patients.
  • INTRODUCTION: The efficacy and feasibility of laparoscopic resection for rectal cancer has been proved, but the results of prospective, randomized studies are not yet available.
  • Here we present a prospective observational study evaluating oncological and clinical outcome after laparoscopic surgery in patients with rectal cancer.
  • PATIENTS AND METHODS: Between January 1998 and March 2005, 225 patients with rectal adenocarcinoma underwent laparoscopic surgery at the University of Regensburg Medical Center.
  • RESULTS: The distribution of the International Union against Cancer (UICC) stages was: 37.7% stage I, 20.5% stage II, 24.9% stage III, and 16.9% stage IV.
  • CONCLUSIONS: Our results demonstrate the efficacy and technical feasibility of laparoscopic surgery for rectal cancer regarding the perioperative morbidity and the oncological outcome.
  • [MeSH-major] Adenocarcinoma / surgery. Laparoscopy. Rectal Neoplasms / surgery

  • Genetic Alliance. consumer health - Rectal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 2004 May 13;350(20):2050-9 [15141043.001]
  • [Cites] Dis Colon Rectum. 2002 Nov;45(11):1481-5 [12432295.001]
  • [Cites] Dis Colon Rectum. 2003 Aug;46(8):1047-53 [12907898.001]
  • [Cites] Br J Surg. 2004 Sep;91(9):1111-24 [15449261.001]
  • [Cites] J Am Coll Surg. 2003 Aug;197(2):177-81 [12892794.001]
  • [Cites] Dis Colon Rectum. 2003 May;46(5):601-11 [12792435.001]
  • [Cites] Lancet. 2005 May 14-20;365(9472):1718-26 [15894098.001]
  • [Cites] Dis Colon Rectum. 2006 Aug;49(8):1108-15 [16763756.001]
  • [Cites] Lancet. 2004 Apr 10;363(9416):1187-92 [15081650.001]
  • [Cites] Chirurg. 2006 Aug;77(8):709-17 [16799790.001]
  • [Cites] J Clin Oncol. 2007 Jul 20;25(21):3061-8 [17634484.001]
  • [Cites] Dis Colon Rectum. 1998 Aug;41(8):963-70 [9715150.001]
  • [Cites] Ann Surg. 2002 Dec;236(6):759-66; disscussion 767 [12454514.001]
  • [Cites] Chirurg. 2003 Apr;74(4):290-300 [12719870.001]
  • [Cites] Dis Colon Rectum. 2001 Feb;44(2):217-22 [11227938.001]
  • [Cites] Surg Endosc. 2003 Oct;17(10):1530-5 [12874687.001]
  • [Cites] Surg Endosc. 2002 Jan;16(1):7-13 [11961595.001]
  • [Cites] Ann Surg. 2003 Mar;237(3):335-42 [12616116.001]
  • [Cites] Dis Colon Rectum. 2000 Mar;43(3):326-32 [10733113.001]
  • [Cites] Surg Endosc. 2000 Jan;14(1):67-70 [10653240.001]
  • [Cites] Br J Surg. 2003 Apr;90(4):445-51 [12673746.001]
  • [Cites] Dis Colon Rectum. 1997 May;40(5):592-6 [9152190.001]
  • [Cites] Zentralbl Chir. 1997;122(12):1134-41 [9499540.001]
  • [Cites] J Am Coll Surg. 1998 Jul;187(1):46-54; discussion 54-5 [9660024.001]
  • [Cites] Lancet. 2002 Jun 29;359(9325):2224-9 [12103285.001]
  • [Cites] Surg Endosc. 2005 Nov;19(11):1468-74 [16222464.001]
  • [Cites] Dis Colon Rectum. 2002 Jul;45(7):867-72; discussion 872-5 [12130871.001]
  • [Cites] Dis Colon Rectum. 1999 Mar;42(3):356-62 [10223756.001]
  • [Cites] N Engl J Med. 2004 Oct 21;351(17):1731-40 [15496622.001]
  • [Cites] Surg Endosc. 2002 Jun;16(6):989-95 [12163970.001]
  • [Cites] Dis Colon Rectum. 2001 Mar;44(3):315-21 [11289275.001]
  • [Cites] Dig Dis. 2005;23(2):127-34 [16352892.001]
  • [Cites] Surg Endosc. 2005 Mar;19(3):307-10 [15624051.001]
  • [Cites] Dis Colon Rectum. 1999 Jul;42(7):930-9 [10411441.001]
  • [Cites] Surg Endosc. 2001 Feb;15(2):116-20 [11285950.001]
  • [Cites] Dis Colon Rectum. 2000 Nov;43(11):1503-11 [11089583.001]
  • [Cites] Br J Surg. 2001 Jun;88(6):801-7 [11412248.001]
  • [Cites] Ann Surg Oncol. 2006 Mar;13(3):413-24 [16450220.001]
  • [Cites] Surg Endosc. 2004 Feb;18(2):281-9 [14691716.001]
  • [Cites] Dis Colon Rectum. 2001 Jan;44(1):10-8; discussion 18-9 [11805558.001]
  • [Cites] Surg Endosc. 2006 Apr;20(4):546-53 [16508815.001]
  • (PMID = 18622560.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


20. Wang LW, Yang SH, Lin JK, Lin TC, Chan WK, Chen WS, Wang HS, Jiang JK, Lee RC, Li AF, Chao Y, Chi KH, Yen SH: Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer. J Surg Oncol; 2005 Mar 15;89(4):256-63; discussion 263-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer.
  • BACKGROUND: To evaluate the efficacy and toxicity of pre-operative radiotherapy (RT) combined with oral tegafur-uracil (UFUR) plus leucovorin (LV) in rectal cancer.
  • PATIENTS: Sixty-five patients with rectal adenocarcinoma (clinical staged T2-4N0-2M0) received pelvic RT of 45 Gy in 20 fractions over 28 days.
  • CONCLUSIONS: Oral UFUR + LV administered with pre-operative RT are effective in tumor DS, pathological complete response, and sphincter preservation with tolerable toxicity in rectal cancer.
  • [MeSH-major] Adenocarcinoma / drug therapy. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Rectal Neoplasms / drug therapy

  • Genetic Alliance. consumer health - Oral cancer.
  • Genetic Alliance. consumer health - Rectal Cancer.
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Surg Oncol. 2005 May 1;90(2):106-7 [15844186.001]
  • [ErratumIn] J Surg Oncol. 2005 May 1;90(2):106
  • (PMID = 15726610.001).
  • [ISSN] 0022-4790
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Drug Combinations; 0 / UFT(R) drug; 1548R74NSZ / Tegafur; 56HH86ZVCT / Uracil; Q573I9DVLP / Leucovorin
  •  go-up   go-down


21. Elshazly WG, Farouk M, Samy M: Preoperative concomitant radiotherapy with oral capecitabine in advanced rectal cancer within 6 cm from anal verge. Int J Colorectal Dis; 2009 Apr;24(4):401-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative concomitant radiotherapy with oral capecitabine in advanced rectal cancer within 6 cm from anal verge.
  • AIM: This study aimed to evaluate the role preoperative chemo-radiotherapy with oral capacitabine for advanced low rectal cancer within 6 cm of anal verge.
  • PATIENTS AND METHODS: Twenty-six patients with rectal adenocarcinoma were treated with preoperative radiotherapy, and oral capecitabine administrated at 5 days/week.
  • [MeSH-major] Anal Canal / pathology. Antimetabolites, Antineoplastic / therapeutic use. Deoxycytidine / analogs & derivatives. Fluorouracil / analogs & derivatives. Preoperative Care. Rectal Neoplasms / drug therapy. Rectal Neoplasms / radiotherapy
  • [MeSH-minor] Administration, Oral. Adult. Capecitabine. Combined Modality Therapy. Female. Humans. Male. Middle Aged. Neoplasm Staging. Patient Compliance. Survival Analysis. Treatment Outcome

  • Genetic Alliance. consumer health - Anal Cancer.
  • Genetic Alliance. consumer health - Oral cancer.
  • Genetic Alliance. consumer health - Rectal Cancer.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 2006 Oct 1;24(28):4620-5 [17008704.001]
  • [Cites] Br J Surg. 1978 Oct;65(10):695-8 [709078.001]
  • [Cites] Surgery. 1997 Oct;122(4):779-84; discussion 784-5 [9347856.001]
  • [Cites] J Clin Oncol. 1998 Jan;16(1):301-8 [9440757.001]
  • [Cites] Lancet. 1991 Nov 9;338(8776):1166-9 [1682591.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1998 Feb 1;40(3):569-74 [9486606.001]
  • [Cites] N Engl J Med. 2006 Sep 14;355(11):1114-23 [16971718.001]
  • [Cites] Anticancer Res. 2007 Jan-Feb;27(1B):541-5 [17348439.001]
  • [Cites] Br J Surg. 1994 Sep;81(9):1376-8 [7953423.001]
  • [Cites] Ann Oncol. 2003 Dec;14(12):1735-43 [14630678.001]
  • [Cites] Eur J Cancer. 1998 Jul;34(8):1274-81 [9849491.001]
  • [Cites] Neth J Med. 2008 Feb;66(2):71-6 [18292610.001]
  • [Cites] Br J Surg. 1982 Jun;69(6):301-4 [7082951.001]
  • [Cites] Ann Surg. 1995 Jan;221(1):67-73 [7826163.001]
  • [Cites] Dis Colon Rectum. 1997 May;40(5):515-22 [9152176.001]
  • [Cites] Clin Cancer Res. 1999 Oct;5(10):2948-53 [10537364.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):762-71 [17011451.001]
  • [Cites] J Clin Oncol. 1998 Nov;16(11):3537-41 [9817272.001]
  • [Cites] N Engl J Med. 2004 Oct 21;351(17):1731-40 [15496622.001]
  • [Cites] Ann Oncol. 2006 Feb;17(2):246-51 [16282246.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1993 Nov 15;27(4):779-83 [8244805.001]
  • [Cites] Ann Surg Oncol. 2000 Mar;7(2):125-32 [10761791.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):346-53 [15913913.001]
  • [Cites] N Engl J Med. 1994 Aug 25;331(8):502-7 [8041415.001]
  • [Cites] Cancer Chemother Pharmacol. 2000;45(4):291-7 [10755317.001]
  • [Cites] Dis Colon Rectum. 1999 Oct;42(10):1272-5 [10528763.001]
  • [Cites] Br J Cancer. 2007 Nov 19;97(10):1333-7 [17987042.001]
  • [Cites] J Clin Oncol. 2002 Oct 1;20(19):3983-91 [12351595.001]
  • [Cites] Dis Colon Rectum. 1999 Sep;42(9):1168-75 [10496557.001]
  • [Cites] Eur J Cancer. 2002 Feb;38 Suppl 2:15-20 [11841931.001]
  • [Cites] Dis Colon Rectum. 1997 Feb;40(2):131-9 [9075745.001]
  • [Cites] Br J Cancer. 2004 Sep 13;91(6):1019-24 [15305186.001]
  • (PMID = 19084971.001).
  • [ISSN] 1432-1262
  • [Journal-full-title] International journal of colorectal disease
  • [ISO-abbreviation] Int J Colorectal Dis
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; U3P01618RT / Fluorouracil
  •  go-up   go-down


22. Min BS, Kim NK, Ko YT, Lee KY, Baek SH, Cho CH, Sohn SK: Long-term oncologic results of patients with distal rectal cancer treated by local excision with or without adjuvant treatment. Int J Colorectal Dis; 2007 Nov;22(11):1325-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term oncologic results of patients with distal rectal cancer treated by local excision with or without adjuvant treatment.
  • AIM: The aim of this study is to review long-term oncologic results of local excision (LE) and to investigate the validity and feasibility of LE as a treatment option for distal rectal cancer.
  • MATERIALS AND METHODS: Seventy-six patients who underwent LE for distal rectal adenocarcinoma with curative intent from 1991 to 2000 at Severance Hospital Yonsei University Medical Center, Seoul, Korea were enrolled in this study.
  • Postoperative pathologic examination revealed 10 cases of pT0 (where no residual cancer cells remained), 11 cases of pTis, 37 cases of pT1, 16 cases of pT2, and 2 cases of pT3.
  • Among the patients with pT1 cancer, those who received adjuvant radiation therapy demonstrated a 5-year LFS of 100%, compared to those who did not, 76.0% (p = 0.038).
  • CONCLUSION: Our results imply a potential role of LE and adjuvant radiation as an option for the treatment of distal rectal cancer, and that even for pT1 carcinoma, LE alone might not be a valid modality.
  • [MeSH-major] Rectal Neoplasms / radiotherapy. Rectal Neoplasms / surgery

  • Genetic Alliance. consumer health - Rectal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Surg. 2001 Sep;234(3):352-8; discussion 358-9 [11524588.001]
  • [Cites] J Clin Oncol. 2005 Aug 1;23(22):4905-12 [16051945.001]
  • [Cites] Int J Colorectal Dis. 2007 May;22(5):507-13 [17009009.001]
  • [Cites] Dis Colon Rectum. 2006 Mar;49(3):345-52 [16532369.001]
  • [Cites] Int J Cancer. 2001;96 Suppl:89-96 [11992391.001]
  • [Cites] World J Surg. 2000 Sep;24(9):1061-8 [11036283.001]
  • [Cites] Am Surg. 2000 Sep;66(9):817-20 [10993607.001]
  • [Cites] Arch Surg. 1999 Aug;134(8):863-7; discussion 867-8 [10443810.001]
  • [Cites] Am J Surg. 2001 Feb;181(2):133-7 [11425053.001]
  • [Cites] World J Surg. 1997 Sep;21(7):706-14 [9276701.001]
  • [Cites] J Am Coll Surg. 2002 May;194(5):584-90; discussion 590-1 [12025835.001]
  • [Cites] Ann Chir. 2001 Sep;126(7):639-43 [11676234.001]
  • [Cites] Curr Treat Options Oncol. 2000 Dec;1(5):399-405 [12057147.001]
  • [Cites] Dis Colon Rectum. 2002 Feb;45(2):200-6 [11852333.001]
  • [Cites] Am Surg. 2001 Aug;67(8):774-9 [11510582.001]
  • [Cites] Int J Colorectal Dis. 1995;10(2):73-6 [7636375.001]
  • [Cites] Arch Surg. 1993 May;128(5):545-9; discussion 549-50 [8489388.001]
  • [Cites] Dis Colon Rectum. 2000 Aug;43(8):1064-71; discussion 1071-4 [10950004.001]
  • [Cites] Ann Surg. 2000 Mar;231(3):345-51 [10714627.001]
  • [Cites] Ann Surg Oncol. 1999 Jul-Aug;6(5):433-41 [10458680.001]
  • [Cites] Dis Colon Rectum. 2001 Sep;44(9):1345-61 [11584215.001]
  • (PMID = 17571241.001).
  • [ISSN] 0179-1958
  • [Journal-full-title] International journal of colorectal disease
  • [ISO-abbreviation] Int J Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


23. Richetti A, Fogliata A, Clivio A, Nicolini G, Pesce G, Salati E, Vanetti E, Cozzi L: Neo-adjuvant chemo-radiation of rectal cancer with volumetric modulated arc therapy: summary of technical and dosimetric features and early clinical experience. Radiat Oncol; 2010;5:14
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neo-adjuvant chemo-radiation of rectal cancer with volumetric modulated arc therapy: summary of technical and dosimetric features and early clinical experience.
  • BACKGROUND: To report about initial technical and clinical experience in preoperative radiation treatment of rectal cancer with volumetric modulated arcs with the RapidArc (RA) technology.
  • All showed locally advanced rectal adenocarcinoma with stage T2-T4, N0-1.
  • CONCLUSION: RA proved to be a safe, qualitatively advantageous treatment modality for rectal cancer, showing some improved results in dosimetric aspects.
  • [MeSH-major] Carcinoma / radiotherapy. Neoadjuvant Therapy / methods. Radiotherapy Planning, Computer-Assisted / methods. Radiotherapy, Intensity-Modulated / methods. Rectal Neoplasms / radiotherapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antineoplastic Agents / therapeutic use. Capecitabine. Deoxycytidine / analogs & derivatives. Deoxycytidine / therapeutic use. Female. Fluorouracil / analogs & derivatives. Fluorouracil / therapeutic use. Humans. Male. Middle Aged. Neoplasm Staging. Radiometry

  • Genetic Alliance. consumer health - Rectal Cancer.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Med Phys. 2006 Aug;33(8):2839-51 [16964860.001]
  • [Cites] Med Phys. 1998 May;25(5):656-61 [9608475.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):204-10 [17084555.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1389-93 [17394942.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1167-72 [17967307.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):413-8 [17904305.001]
  • [Cites] Med Phys. 2008 Jan;35(1):310-7 [18293586.001]
  • [Cites] Radiat Oncol. 2008;3:24 [18782447.001]
  • [Cites] Radiother Oncol. 2008 Nov;89(2):180-91 [18692929.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):636-43 [19014778.001]
  • [Cites] Radiother Oncol. 2008 Dec;89(3):254-62 [18760851.001]
  • [Cites] Acta Oncol. 2009;48(2):227-32 [18855157.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):252-9 [19362244.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):610-5 [19427560.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):673-88 [19480968.001]
  • [Cites] Radiother Oncol. 2009 Jul;92(1):111-7 [19157609.001]
  • [Cites] Radiother Oncol. 2009 Jul;92(1):118-24 [19181409.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1476-80 [19231097.001]
  • [Cites] Br J Cancer. 2009 Sep 15;101(6):924-34 [19690550.001]
  • [Cites] J Clin Oncol. 2009 Nov 1;27(31):5124-30 [19770376.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):505-13 [16879928.001]
  • (PMID = 20170490.001).
  • [ISSN] 1748-717X
  • [Journal-full-title] Radiation oncology (London, England)
  • [ISO-abbreviation] Radiat Oncol
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; U3P01618RT / Fluorouracil
  • [Other-IDs] NLM/ PMC2838920
  •  go-up   go-down


24. Kovacević D, Sonicki Z, Kusić Z, Bolanca A, Grubisić G, Lukac M, Lukac J: Preoperative serum levels of c-erbB-2 do not seem to be useful in management of patients with rectal cancer. Int J Colorectal Dis; 2007 Jul;22(7):827-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative serum levels of c-erbB-2 do not seem to be useful in management of patients with rectal cancer.
  • BACKGROUND AND AIM: Soluble c-erbB-2 oncoprotein has been proven as a useful marker in the management of breast cancer patients, but its value in diagnostics and follow-up of colorectal cancer patients remains controversial.
  • The aim of this study was to evaluate the usefulness of serum c-erbB-2 monitoring in diagnostics and prediction of disease outcome in rectal cancer patients.
  • MATERIALS AND METHODS: Serum samples from 88 patients with rectal adenocarcinoma before surgery and from 41 healthy controls were tested for the presence of c-erbB-2 oncoprotein by ELISA, and the patients were followed up for at least 5 years after the surgery.
  • Elevated preoperative serum c-erbB-2 levels showed relatively high specificity (88%) and low sensitivity (44%) in the diagnosis of rectal cancer.
  • CONCLUSION: Although preoperative serum c-erbB-2 levels were significantly higher in rectal cancer patients than in healthy controls, the soluble c-erbB-2 does not seem to be useful in the diagnosis of rectal cancer due to its low sensitivity.
  • Preoperative serum levels of this oncoprotein were predictive neither for overall survival nor for local recurrence/distant metastases in rectal cancer patients.
  • [MeSH-major] Adenocarcinoma / blood. Biomarkers, Tumor / blood. Colectomy. Receptor, ErbB-2 / blood. Rectal Neoplasms / blood

  • Genetic Alliance. consumer health - Rectal Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oncol Rep. 1999 May-Jun;6(3):527-31 [10203586.001]
  • [Cites] Cancer Lett. 2002 Oct 28;184(2):215-22 [12127694.001]
  • [Cites] Breast Cancer Res Treat. 1992;24(2):97-102 [8095169.001]
  • [Cites] J Biol Chem. 1991 Jan 25;266(3):1716-20 [1671042.001]
  • [Cites] Tumour Biol. 1997;18(3):188-96 [9143415.001]
  • [Cites] J Cancer Res Clin Oncol. 1996;122(2):118-21 [8576278.001]
  • [Cites] Int J Oncol. 1993 Aug;3(2):325-9 [21573368.001]
  • [Cites] Folia Med (Plovdiv). 2003;45(2):12-6 [12943051.001]
  • [Cites] J Clin Oncol. 1995 May;13(5):1129-35 [7738618.001]
  • [Cites] Anticancer Res. 1998 Jul-Aug;18(4B):2891-4 [9713482.001]
  • [Cites] J Clin Oncol. 1992 Sep;10(9):1436-43 [1355522.001]
  • [Cites] Tumour Biol. 2002 Mar-Apr;23(2):70-5 [12065844.001]
  • [Cites] Br J Cancer. 1994 Oct;70(4):739-42 [7522511.001]
  • (PMID = 17119985.001).
  • [ISSN] 0179-1958
  • [Journal-full-title] International journal of colorectal disease
  • [ISO-abbreviation] Int J Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Carcinoembryonic Antigen; EC 2.7.10.1 / Receptor, ErbB-2
  •  go-up   go-down


25. Sanchez LD, Chelliah T, Meisher I, Niranjan S: Rare case of breast tumor secondary to rectal adenocarcinoma. South Med J; 2008 Oct;101(10):1062-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rare case of breast tumor secondary to rectal adenocarcinoma.
  • Primary breast cancer is the most common malignancy in women.
  • Metastatic cancer to the breast is very rare.
  • Colorectal cancers usually metastasize to the liver and the lung; other sites of metastasis from colon cancer are uncommon and are usually found in association with extensive liver and/or lung metastases.
  • This is a report of a rare case of aggressive rectal cancer with metastasis to the breast without liver or lung metastases.
  • [MeSH-major] Adenocarcinoma / secondary. Breast Neoplasms / secondary. Rectal Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18791504.001).
  • [ISSN] 1541-8243
  • [Journal-full-title] Southern medical journal
  • [ISO-abbreviation] South. Med. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


26. Moparty B, Gomez G, Bhutani MS: Large solitary ovarian metastasis from colorectal cancer diagnosed by endoscopic ultrasound. World J Gastroenterol; 2008 Aug 28;14(32):5096-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Large solitary ovarian metastasis from colorectal cancer diagnosed by endoscopic ultrasound.
  • A case is presented of rectal carcinoma in which during staging by endoscopic ultrasound (EUS) a second large extrarectal mass was seen not otherwise visualized on computer tomography (CT) that was a solitary ovarian metastasis.
  • On retrospective review of the CT pelvis after surgery, the radiologist could still not diagnose the ovarian lesion separated from the primary rectal tumor due to their close proximity.
  • However, on EUS we were able to clearly see on real-time imaging that there was a distinct peri-rectal mass apart from the primary rectal tumor.
  • [MeSH-major] Adenocarcinoma / secondary. Adenocarcinoma / ultrasonography. Colorectal Neoplasms / pathology. Ovarian Neoplasms / secondary. Ovarian Neoplasms / ultrasonography


27. Derin D, Eralp Y, Guney N, Ozlük Y, Topuz E: Ovarian carcinoma with simultaneous breast and rectum metastases. Onkologie; 2008 Apr;31(4):200-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ovarian carcinoma with simultaneous breast and rectum metastases.
  • BACKGROUND: Metastatic involvement of the breast and the rectum from ovarian carcinoma are very rare events.
  • CASE REPORT: We report a case of ovarian carcinoma with metastasis to the breast and rectum simultaneously, 6 years after initial diagnosis.
  • RESULTS: Morphologic and immunohistochemical findings from pathologic samples of all involved sites confirmed the ovarian origin, which spared the patient unnecessary breast and rectal surgery.
  • To our knowledge, this is the first case of ovarian carcinoma with simultaneous metastases to the breast and rectum reported to date.
  • CONCLUSION: Accurate differential diagnosis from primary breast and rectal carcinoma is very important because the prognosis and treatment differ significantly.
  • [MeSH-major] Breast Neoplasms / pathology. Breast Neoplasms / secondary. Cystadenocarcinoma, Papillary / pathology. Cystadenocarcinoma, Papillary / secondary. Ovarian Neoplasms / pathology. Rectal Neoplasms / pathology. Rectal Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2008 S. Karger AG, Basel.
  • (PMID = 18418023.001).
  • [ISSN] 1423-0240
  • [Journal-full-title] Onkologie
  • [ISO-abbreviation] Onkologie
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


28. Lupattelli M, Maranzano E, Bellavita R, Natalini G, Corgna E, Rossetti R, Trippa F, Mascioni F, Sidoni A, Anselmo P, Buzzi F, Brugia M, Latini P: Raltitrexed and radiotherapy as adjuvant treatment for stage II-III rectal cancer: a feasibility study. Tumori; 2005 Nov-Dec;91(6):498-504
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Raltitrexed and radiotherapy as adjuvant treatment for stage II-III rectal cancer: a feasibility study.
  • AIMS AND BACKGROUND: Adjuvant 5-FU chemotherapy plus radiotherapy represents the standard treatment for radically resected rectal cancer at high risk of relapse according to the NIH Consensus Conference.
  • The aim of this prospective multicenter phase II study was to evaluate the feasibility, gastrointestinal and hematological acute toxicity of raltitrexed in combination with radiotherapy in rectal cancer patients.
  • METHODS: From September 2000 to June 2004, 50 patients with radically resected stage II-III rectal adenocarcinoma were treated.
  • [MeSH-major] Adenocarcinoma / drug therapy. Adenocarcinoma / radiotherapy. Antimetabolites, Antineoplastic / therapeutic use. Quinazolines / therapeutic use. Rectal Neoplasms / drug therapy. Rectal Neoplasms / radiotherapy. Thiophenes / therapeutic use. Thymidylate Synthase / antagonists & inhibitors
  • [MeSH-minor] Adult. Aged. Chemotherapy, Adjuvant. Drug Administration Schedule. Enzyme Inhibitors / therapeutic use. Feasibility Studies. Female. Humans. Male. Middle Aged. Neoplasm Staging. Patient Compliance. Prospective Studies. Radiotherapy Dosage. Radiotherapy, Adjuvant. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16457149.001).
  • [ISSN] 0300-8916
  • [Journal-full-title] Tumori
  • [ISO-abbreviation] Tumori
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Multicenter Study
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Enzyme Inhibitors; 0 / Quinazolines; 0 / Thiophenes; EC 2.1.1.45 / Thymidylate Synthase; FCB9EGG971 / raltitrexed
  •  go-up   go-down


29. Zhou JN, Wang DZ, Huang XE, Xu FP, Shang JQ, Gu RM: Transabdominal transanal resection of distal rectal cancer after high dose preoperative radiotherapy: a Chinese experience in preserving sphincter function. Isr Med Assoc J; 2006 Oct;8(10):675-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transabdominal transanal resection of distal rectal cancer after high dose preoperative radiotherapy: a Chinese experience in preserving sphincter function.
  • METHODS: From September 1994 to September 2000, 25 consecutive patients with pathologically confirmed distal rectal adenocarcinoma were treated preoperatively with a total dose of 45-46 Gy at 1.8-2.0 Gy per fraction during 5 weeks.
  • CONCLUSIONS: High dose preoperative radiotherapy and TATA as a sphincter-preserving method was feasible and efficient in Chinese patients with distal rectal cancer.
  • [MeSH-major] Abdomen / surgery. Adenocarcinoma / radiotherapy. Adenocarcinoma / surgery. Anal Canal / physiopathology. Anal Canal / surgery. Rectal Neoplasms / radiotherapy. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. China. Combined Modality Therapy / methods. Feasibility Studies. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Postoperative Complications. Preoperative Care / methods. Radiation Injuries / etiology. Radiotherapy Dosage. Rectum / radiation effects. Rectum / surgery. Survival Analysis. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Isr Med Assoc J. 2006 Oct;8(10):711-2 [17125121.001]
  • (PMID = 17125111.001).
  • [ISSN] 1565-1088
  • [Journal-full-title] The Israel Medical Association journal : IMAJ
  • [ISO-abbreviation] Isr. Med. Assoc. J.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Israel
  •  go-up   go-down


30. Braat AE, Oosterhuis JW, Moll FC, de Vries JE, Wiggers T: Sentinel node detection after preoperative short-course radiotherapy in rectal carcinoma is not reliable. Br J Surg; 2005 Dec;92(12):1533-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sentinel node detection after preoperative short-course radiotherapy in rectal carcinoma is not reliable.
  • BACKGROUND: Sentinel node (SN) detection may be used in patients with colonic carcinoma.
  • However, its use in patients with rectal carcinoma may be unreliable.
  • To address this, SN detection was evaluated in patients with rectal carcinoma after short-course preoperative radiotherapy.
  • In addition, SN detection was performed in 57 patients with colonic carcinoma.
  • RESULTS: A SN was identified in 26 of 34 patients with rectal carcinoma.
  • By contrast, SN detection was possible in 56 of 57 patient with colonic carcinoma with a sensitivity of 90 per cent, and four patients were upstaged.
  • CONCLUSION: The SN procedure for rectal carcinoma is not reliable in combination with TME and preoperative short-course radiotherapy.
  • [MeSH-major] Colonic Neoplasms / pathology. Rectal Neoplasms / pathology

  • Hazardous Substances Data Bank. C.I. FOOD BLUE 3 .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2005 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
  • (PMID = 16231281.001).
  • [ISSN] 0007-1323
  • [Journal-full-title] The British journal of surgery
  • [ISO-abbreviation] Br J Surg
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Coloring Agents; 0 / Rosaniline Dyes; 129-17-9 / patent blue violet
  •  go-up   go-down


31. Bebenek M, Wojnar A: Infralevator lymphatic drainage of low-rectal cancers: preliminary results. Ann Surg Oncol; 2009 Apr;16(4):887-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Infralevator lymphatic drainage of low-rectal cancers: preliminary results.
  • BACKGROUND: Some low-rectal cancers may spread into or recur in the inguinal lymph nodes despite optimal resection of the primary tumor.
  • Hence, we hypothesized that lymphatic drainage of low-rectal malignancies may be inhomogeneous and that an extramesorectal route may be involved in at least some cases.
  • The idea of our preliminary study was to analyze the potential lymphatic drainages in low-rectal cancer patients.
  • METHODS: The first stage of the experiment included two consecutive low-rectal adenocarcinoma patients (free from inguinal lymph node metastases), in whom the lymphatics of the primary tumor were traced with Patentbalu dye.
  • During the second stage the records of 206 consecutive low-rectal cancer patients were analyzed for presence of inguinal lymph node metastases.
  • RESULTS: An evaluation of specimens from two rectal cancer patients revealed extramesorectal lymphatic drainage of the primary tumor besides the mesorectal route.
  • They were all diagnosed with rectal adenocarcinoma, T3 or T4 tumors with G2 or G3 grade.
  • CONCLUSION: The demonstration of an alternative route of lymphatic drainage suggests that more radical surgical procedures are necessary for successful treatment of low-rectal cancers.
  • [MeSH-major] Adenocarcinoma / pathology. Rectal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19165544.001).
  • [ISSN] 1534-4681
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Coloring Agents
  •  go-up   go-down


32. Warchoł R, Szymański L, Seichter A: [Rectal adenocarcinoma metastasis to the facial skin--case report]. Otolaryngol Pol; 2008;62(1):96-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Rectal adenocarcinoma metastasis to the facial skin--case report].
  • INTRODUCTION: Carcinoma of the large intestine is a common and relatively well known neoplastic malignancy of the digestive tract.
  • 9 months earlier he underwent anterior resection of rectum due to carcinoma.
  • Histopatological examination of specimen from the facial skin lesion revealed adenocarcinoma cells.
  • RESULTS AND CONCLUSIONS: We present this case report as an example of an unusual and rare secondary malignancy of head and neck, emphasizing the interdisciplinary character of oncological treatment and the role of oncological vigilance on every step of diagnosis.
  • [MeSH-major] Adenocarcinoma / secondary. Facial Neoplasms / secondary. Rectal Neoplasms / pathology. Skin Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18637429.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  • [Chemical-registry-number] Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil
  •  go-up   go-down


33. Lidder PG, Hosie KB: Rectal cancer: the role of radiotherapy. Dig Surg; 2005;22(1-2):41-8; discussion 49
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rectal cancer: the role of radiotherapy.
  • Surgery is the definitive tool in the management of patients with rectal carcinoma.
  • This article examines the role of radiotherapy in the management of patients with rectal carcinoma and explores the controversies that exist in its application.
  • [MeSH-major] Rectal Neoplasms / radiotherapy
  • [MeSH-minor] Humans. Neoadjuvant Therapy. Neoplasm Recurrence, Local. Palliative Care. Radiotherapy Dosage. Radiotherapy, Adjuvant

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15838170.001).
  • [ISSN] 0253-4886
  • [Journal-full-title] Digestive surgery
  • [ISO-abbreviation] Dig Surg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  • [Number-of-references] 45
  •  go-up   go-down


34. Yamamoto S, Fujita S, Akasu T, Moriya Y: Safety of laparoscopic intracorporeal rectal transection with double-stapling technique anastomosis. Surg Laparosc Endosc Percutan Tech; 2005 Apr;15(2):70-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Safety of laparoscopic intracorporeal rectal transection with double-stapling technique anastomosis.
  • To assess the feasibility and analyze the short-term outcomes of laparoscopic intracorporeal rectal transection with double-stapling technique anastomosis, a review was performed of a prospective registry of 67 patients who underwent laparoscopic sigmoidectomy and anterior resection with intracorporeal rectal transection and double-stapling technique anastomosis between July 2001 and January 2004.
  • Patients were divided into 3 groups: sigmoid colon/rectosigmoid carcinoma, upper rectal carcinoma, and middle/lower rectal carcinoma.
  • The number of cartridges required in bowel transection was significantly increased in patients with middle/lower rectal carcinoma, and significant differences were observed in the length of the first stapler cartridge fired for rectal transection.
  • Furthermore, mean operative time and blood loss were also significantly greater in the middle/lower rectum group; however, complication rates and postoperative course were similar among the 3 groups.
  • Laparoscopic intracorporeal rectal transection with double-stapling technique anastomosis can be performed safely without increased morbidity or mortality.
  • [MeSH-major] Anastomosis, Surgical / methods. Carcinoma / surgery. Colorectal Neoplasms / surgery. Laparoscopy / adverse effects. Rectum / surgery. Surgical Stapling / methods

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15821617.001).
  • [ISSN] 1530-4515
  • [Journal-full-title] Surgical laparoscopy, endoscopy & percutaneous techniques
  • [ISO-abbreviation] Surg Laparosc Endosc Percutan Tech
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


35. Zhang W, Ho KS, Han HJ, Kong CS, Eu KW: Successful resuscitation after carbon dioxide embolism during laparoscopic-assisted abdomino-perineal resection. Singapore Med J; 2005 Jul;46(7):347-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report a 67-year-old woman who underwent laparoscopic-assisted abdomino-perineal resection for rectal carcinoma.
  • [MeSH-minor] Aged. Carbon Dioxide. Female. Humans. Laparoscopy. Posture. Rectal Neoplasms / surgery

  • Genetic Alliance. consumer health - Embolism.
  • Hazardous Substances Data Bank. Carbon dioxide .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15968448.001).
  • [ISSN] 0037-5675
  • [Journal-full-title] Singapore medical journal
  • [ISO-abbreviation] Singapore Med J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Singapore
  • [Chemical-registry-number] 142M471B3J / Carbon Dioxide
  •  go-up   go-down


36. Kelley ST, Coppola D, Yeatman T, Marcet J: Tumor response to neoadjuvant chemoradiation therapy for rectal adenocarcinoma is mediated by p53-dependent and caspase 8-dependent apoptotic pathways. Clin Colorectal Cancer; 2005 Jul;5(2):114-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tumor response to neoadjuvant chemoradiation therapy for rectal adenocarcinoma is mediated by p53-dependent and caspase 8-dependent apoptotic pathways.
  • BACKGROUND: We tested the hypothesis that rectal tumors are most responsive to neoadjuvant therapy if they possess p53 and/or caspase 8 activity.
  • PATIENTS AND METHODS: Fifty patients diagnosed with biopsy-proven rectal cancer underwent neoadjuvant chemoradiation therapy consisting of 5-fluorouracil (300 mg/m(2) daily) and radiation (4,500 cGy).
  • Endorectal ultrasonography was performed before and after neoadjuvant therapy along with digital rectal examination and/or sigmoidoscopy for staging purposes and to evaluate response to therapy.
  • There were 10 stage I tumors (20%), 22 stage II tumors (44%), and 18 stage III tumors (36%) in the cohort at the time of initial diagnosis. p53 protein staining (ie, mutated p53) was positive in 31 tumors (62%; CR, n = 8; PR, n = 11; NR, n = 12); caspase 8 positivity was apparent in 30 specimens (60%; CR, n = 13; PR, n = 13; NR, n = 4).
  • [MeSH-major] Adenocarcinoma / therapy. Caspases / metabolism. Neoadjuvant Therapy. Rectal Neoplasms / therapy. Tumor Suppressor Protein p53 / metabolism

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16098252.001).
  • [ISSN] 1533-0028
  • [Journal-full-title] Clinical colorectal cancer
  • [ISO-abbreviation] Clin Colorectal Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Biomarkers; 0 / Tumor Suppressor Protein p53; EC 3.4.22.- / CASP8 protein, human; EC 3.4.22.- / Caspase 8; EC 3.4.22.- / Caspases; U3P01618RT / Fluorouracil
  •  go-up   go-down


37. Bertelsen CA, Andreasen AH, Jørgensen T, Harling H, Danish Colorectal Cancer Group: Anastomotic leakage after curative anterior resection for rectal cancer: short and long-term outcome. Colorectal Dis; 2010 Jul;12(7 Online):e76-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Anastomotic leakage after curative anterior resection for rectal cancer: short and long-term outcome.
  • OBJECTIVE: The influence of symptomatic anastomotic leakage (AL) after anterior resection (AR) for rectal cancer on short and long-term mortality and local and distant recurrence was analysed.
  • METHOD: All patients with a first diagnosis of rectal carcinoma were prospectively registered in a national database.
  • CONCLUSION: Anastomotic leakage after AR for rectal cancer increases the 30-day and long-term mortality, but AL did not increase the risk of local and distant recurrence.
  • [MeSH-major] Colectomy / adverse effects. Rectal Neoplasms / surgery. Rectum / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Anastomosis, Surgical / adverse effects. Anastomosis, Surgical / mortality. Denmark / epidemiology. Female. Follow-Up Studies. Humans. Incidence. Male. Middle Aged. Neoplasm Recurrence, Local / epidemiology. Postoperative Complications. Prognosis. Prospective Studies. Risk Factors. Survival Rate / trends. Time Factors. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Rectal Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19438879.001).
  • [ISSN] 1463-1318
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Multicenter Study
  • [Publication-country] England
  • [Investigator] Gustafsen J; Wille-Jorgensen P; Bülow S; Wied U; Raskov HH; Crone P; Ronholt C; Hansen OH; Jess P; Kirkeby L; Iversen E; Haakansson T; Andersen OB; Nymark J; Lawaetz O; Rahr H; Madsen P; V Andersen P; Buch N; Teglaard P; Jensen KE; Berg V; Thomsen H; Klaerke M; Bisgaard C; Sloth H; Madsen MR; Madsen G; Christensen H; Nielsen JD; Mark M; Lausten-Thomsen HH; Nord S; Gandrup P; Lauesen N; Lundhus E; Malling N
  •  go-up   go-down


38. Kume S, Kubota T, Takahashi M, Hashimoto D, Hirata T, Torigoe Y, Ikeda O: [A case of locally advanced rectal cancer responding to FOLFOX]. Gan To Kagaku Ryoho; 2009 Apr;36(4):659-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of locally advanced rectal cancer responding to FOLFOX].
  • The 57-year-old man was underwent sigmoid colostomy due to unresectable rectal carcinoma.
  • Preoperative chemotherapy with FOLFOX appears a promising regimen for patients with unresectable rectal cancer.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Rectal Neoplasms / drug therapy. Rectal Neoplasms / pathology
  • [MeSH-minor] Fluorouracil / therapeutic use. Humans. Leucovorin / therapeutic use. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Invasiveness / pathology. Neoplasm Staging. Organoplatinum Compounds / therapeutic use. Proctoscopy

  • Genetic Alliance. consumer health - Rectal Cancer.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19381043.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Organoplatinum Compounds; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil; Folfox protocol
  •  go-up   go-down


39. Wu ZY, Wan J, Li JH, Zhao G, Peng L, Yao Y, Du JL, Liu QF, Wang ZD, Huang ZM, Lin HH: Study of circumferential resection margin in patients with middle and lower rectal carcinoma. World J Gastroenterol; 2007 Jun 28;13(24):3380-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Study of circumferential resection margin in patients with middle and lower rectal carcinoma.
  • AIM: To clarify the relationship between circumferential resection margin status and local and distant recurrence as well as survival of patients with middle and lower rectal carcinoma.
  • The relationship between circumferential resection margin status and clinicopathologic characteristics of middle and lower rectal carcinoma was also evaluated.
  • METHODS: Cancer specimens from 56 patients with middle and lower rectal carcinoma who received total mesorectal excision at the Department of General Surgery of Guangdong Provincial People's Hospital were studied.
  • RESULTS: Local recurrence occurred in 12.5% (7 of 56 cases) of patients with middle and lower rectal carcinoma.
  • Distant recurrence occurred in 25% (14 of 56 cases) of patients with middle and lower rectal carcinoma.
  • In 18 cancer specimens with tumor diameter >= 5 cm 7 (38.9%) were detected as positive circumferential resection margin, while in 38 cancer specimens with a tumor diameter of < 5 cm only 5 (13.2%) were positive for circumferential resection margin (P = 0.028).
  • The circumferential resection margin status is an important predictor of local and distant recurrence as well as survival of patients with middle and lower rectal carcinoma.
  • [MeSH-major] Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17659680.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC4172721
  •  go-up   go-down


40. Radonak J, Lakyová L, Toporcer T: [Uncommon rectal adenocarcinoma metastases]. Rozhl Chir; 2010 Aug;89(7):441-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Uncommon rectal adenocarcinoma metastases].
  • [Transliterated title] Nezvycajné metastazovanie adenokarcinómu rekta.
  • Rectal cancer treatment has become multimodal as a result of significant advances in imaging diagnostic, in surgery technique of re section and in neo and adjuvant therapy.
  • The aim of the case report was to present a successfully treated adenocarcinoma recti and adenocarcinoma of hepatal flexurae with recidivistic metastasis and an extremely rare intergrowth of the metastasis into venous system.
  • A 61 year old patient underwent low resection of recti according to Dixon because of well differentiated adenocarcinoma with classification T3N0M0.
  • The patient was reoperated because of metastasis of adenocarcinoma in the abdominal wall (16 x 15 x 20 cm) after chemotherapy (FUL-5-fluorouracyl) and radiation dose of 50.4 Gy.
  • 26 months after the first operation, a new sessile polyp was found in the hepatal flexurae with histological finding of well differentiated adenocarcinoma.
  • [MeSH-major] Abdominal Neoplasms / secondary. Abdominal Wall. Adenocarcinoma / secondary. Rectal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20925261.001).
  • [ISSN] 0035-9351
  • [Journal-full-title] Rozhledy v chirurgii : měsíčník Československé chirurgické společnosti
  • [ISO-abbreviation] Rozhl Chir
  • [Language] slo
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Czech Republic
  •  go-up   go-down


41. Zbar AP, Bernstein S, Greaves N, Iniss M, Shenoy RK: The utilization of intraluminal formalin for intractable rectal haemorrhage in advanced rectal cancer: a case report. Tech Coloproctol; 2005 Apr;9(1):49-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The utilization of intraluminal formalin for intractable rectal haemorrhage in advanced rectal cancer: a case report.
  • A patient with a metastatic fixed low rectal carcinoma presented severe rectal bleeding requiring massive transfusion over with a 36-hour period.
  • This technique has been reserved for intractable transfusion-dependent radiation proctitis and is presented as a primary alternative in severe rectal bleeding from inoperable rectal cancer.
  • [MeSH-major] Formaldehyde / therapeutic use. Gastrointestinal Hemorrhage / therapy. Rectal Neoplasms / complications
  • [MeSH-minor] Administration, Rectal. Adult. Female. Humans

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - Gastrointestinal Bleeding.
  • Hazardous Substances Data Bank. FORMALDEHYDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15868500.001).
  • [ISSN] 1123-6337
  • [Journal-full-title] Techniques in coloproctology
  • [ISO-abbreviation] Tech Coloproctol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 1HG84L3525 / Formaldehyde
  •  go-up   go-down


42. Soumarová R, Skrovina M, Machala S, Adamcík L, Bartos J: [Intraoperative radiotherapy in multimodality treatment of locally advanced rectal carcinoma]. Rozhl Chir; 2010 Nov;89(11):685-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intraoperative radiotherapy in multimodality treatment of locally advanced rectal carcinoma].
  • [Transliterated title] Intraoperacní radioterapie v multimodalitní lécbe lokálne pokrocilého karcinomu rekta.
  • Multimodality treatment of locally advanced rectal cancer combines radical surgery, radiotherapy and chemotherapy.
  • [MeSH-major] Rectal Neoplasms / radiotherapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21409803.001).
  • [ISSN] 0035-9351
  • [Journal-full-title] Rozhledy v chirurgii : měsíčník Československé chirurgické společnosti
  • [ISO-abbreviation] Rozhl Chir
  • [Language] cze
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Czech Republic
  •  go-up   go-down


43. Petrie N, Branagan G, McGuiness C, McGee S, Fuller C, Chave H: Reconstruction of the perineum following anorectal cancer excision. Int J Colorectal Dis; 2009 Jan;24(1):97-104
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Reconstruction of the perineum following anorectal cancer excision.
  • PURPOSE: Most patients with anal cancer receive chemoradiotherapy as first-line treatment.
  • A proportion of the 20,000 new cases of rectal carcinoma diagnosed in the UK each year receive neo-adjuvant chemoradiation and then an APR.
  • This study investigates a series of 18 patients who underwent APR for anorectal cancer with flap reconstruction of their perineum.
  • RESULTS: Between November 2000 and October 2007, 18 cases were performed (M/F = 7:11), six for anal cancer and 12 for low rectal tumours.
  • [MeSH-major] Perineum / surgery. Rectal Neoplasms / therapy. Surgical Flaps
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Carcinoma / therapy. Chemotherapy, Adjuvant. Cohort Studies. Female. Humans. Length of Stay. Male. Middle Aged. Neoadjuvant Therapy. Postoperative Complications. Radiotherapy, Adjuvant. Retrospective Studies. Wound Healing

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Plast Reconstr Surg. 2000 Jan;105(1):171-3 [10626987.001]
  • [Cites] Arch Surg. 2001 Aug;136(8):886-91 [11485523.001]
  • [Cites] Lancet. 1996 Oct 19;348(9034):1049-54 [8874455.001]
  • [Cites] Plast Reconstr Surg. 2001 Dec;108(7):1998-2005 [11743391.001]
  • [Cites] Dis Colon Rectum. 2005 Mar;48(3):438-43 [15719190.001]
  • [Cites] Br J Surg. 2005 Apr;92(4):482-6 [15736219.001]
  • [Cites] J Reconstr Microsurg. 1998 Jul;14(5):337-40 [9714040.001]
  • [Cites] Br J Surg. 2003 May;90(5):575-80 [12734865.001]
  • [Cites] Int J Colorectal Dis. 1991 Nov;6(4):193-6 [1770285.001]
  • [Cites] Wound Repair Regen. 1998 May-Jun;6(3):223-33 [9776866.001]
  • [Cites] Br J Surg. 2007 Feb;94(2):232-8 [17143848.001]
  • [Cites] Am J Roentgenol Radium Ther Nucl Med. 1961 May;85:822-33 [13685884.001]
  • [Cites] Dis Colon Rectum. 1980 Nov-Dec;23(8):564-6 [7460694.001]
  • [Cites] Br J Plast Surg. 1996 Dec;49(8):547-54 [8976747.001]
  • [Cites] Ann R Coll Surg Engl. 1984 Sep;66(5):337-9 [6237602.001]
  • [Cites] Plast Reconstr Surg. 1988 Jan;81(1):62-73 [2962215.001]
  • [Cites] CA Cancer J Clin. 1971 Nov-Dec;21(6):361-4 [5001853.001]
  • [Cites] World J Surg. 2005 Nov;29(11):1452-7 [16222445.001]
  • [Cites] Ann Surg Oncol. 2005 Feb;12(2):104-10 [15827789.001]
  • [Cites] Ann Intern Med. 1980 Sep;93(3):480-9 [6254418.001]
  • [Cites] Br J Surg. 1999 Mar;86(3):349-54 [10201777.001]
  • [Cites] Surg Gynecol Obstet. 1981 Nov;153(5):713-6 [7292271.001]
  • [Cites] Am Surg. 2005 Feb;71(2):117-22 [16022009.001]
  • [Cites] Ann R Coll Surg Engl. 1995 May;77(3):229-32 [7598425.001]
  • [Cites] N Engl J Med. 2000 Mar 16;342(11):792-800 [10717015.001]
  • [Cites] Arch Surg. 1990 Oct;125(10):1371-6; discussion 1376-7 [2222178.001]
  • [Cites] J Natl Cancer Inst. 1971 Oct;47(4):865-70 [5097154.001]
  • [Cites] Scand J Plast Reconstr Surg. 1975;9(1):74-6 [1162294.001]
  • [Cites] Dis Colon Rectum. 1974 May-Jun;17(3):354-6 [4830803.001]
  • [Cites] Am J Surg. 1983 Jan;145(1):183-9 [6849490.001]
  • [Cites] Br J Surg. 1990 Jun;77(6):635-7 [2143427.001]
  • [Cites] Am J Surg. 1974 Feb;127(2):215-9 [4812123.001]
  • [Cites] Otolaryngology. 1978 Sep-Oct;86(5):ORL-804-11 [114952.001]
  • [Cites] Ann Plast Surg. 2004 Jan;52(1):22-6 [14676694.001]
  • [Cites] Cancer Res. 1958 Apr;18(3):305-17 [13523597.001]
  • [Cites] Ann Surg Oncol. 1999 Jan-Feb;6(1):33-7 [10030413.001]
  • [Cites] Plast Reconstr Surg. 1988 Oct;82(4):669-77 [3420190.001]
  • [Cites] J Reconstr Microsurg. 1998 May;14(4):263-8 [9618094.001]
  • [Cites] Br J Surg. 2002 Nov;89(11):1425-9 [12390386.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1997 Jul 1;38(4):777-83 [9240646.001]
  • [Cites] Can J Surg. 1987 May;30(3):212-4 [3580983.001]
  • [Cites] Oncologist. 2002;7(3):188-99 [12065790.001]
  • (PMID = 18688618.001).
  • [ISSN] 0179-1958
  • [Journal-full-title] International journal of colorectal disease
  • [ISO-abbreviation] Int J Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


44. Sprenger T, Rothe H, Langer C, Becker H, Liersch T: Comment on "lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival". Am J Surg Pathol; 2009 Jul;33(7):1107; author reply 1108
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comment on "lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival".
  • [MeSH-major] Adenocarcinoma / pathology. Lymphatic Metastasis / pathology. Rectal Neoplasms / pathology
  • [MeSH-minor] Antineoplastic Agents / therapeutic use. Combined Modality Therapy. Humans. Lymph Nodes / pathology. Neoadjuvant Therapy. Neoplasm Staging. Radiotherapy

  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Am J Surg Pathol. 2008 Jan;32(1):45-50 [18162769.001]
  • (PMID = 19390426.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Comment; Letter
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


45. Nicholls J: Local excision of rectal carcinoma. Colorectal Dis; 2007 Nov;9(9):771-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Local excision of rectal carcinoma.
  • [MeSH-major] Adenocarcinoma / surgery. Carcinoma / surgery. Rectal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17931167.001).
  • [ISSN] 1462-8910
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Editorial
  • [Publication-country] England
  •  go-up   go-down


46. Jeyarajah S, Sutton CD, Miller AS, Hemingway D, Leicester Colorectal Specialist Group: Factors that influence the adequacy of total mesorectal excision for rectal cancer. Colorectal Dis; 2007 Nov;9(9):808-15
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Factors that influence the adequacy of total mesorectal excision for rectal cancer.
  • OBJECTIVE: In 1997 with the start of CRO7 trial it was agreed that adequacy of surgical resection of rectal cancer would be determined by a pathologically determined grading of the mesorectum the so called total mesorectal excision score (TME score).
  • METHOD: Data on all patients undergoing resectional surgery for rectal cancer in our unit are entered prospectively onto a database.
  • RESULTS: Between January 2000 and June 2005, 518 patients underwent surgery for adenocarcinoma of the rectum, of these, 287 patients had a total mesorectal excision for mid or lower third tumours under the care of seven colorectal surgeons.
  • CONCLUSION: There is no relationship between the TME score in patients undergoing resectional surgery for adenocarcinoma of the rectum and the development of local recurrence at 2 years.
  • [MeSH-major] Adenocarcinoma / pathology. Adenocarcinoma / surgery. Neoplasm Recurrence, Local. Rectal Neoplasms / pathology. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Rectum / surgery. Survival Analysis. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Colorectal Dis. 2008 Jul;10(6):629; author reply 629-30 [18533007.001]
  • (PMID = 17441969.001).
  • [ISSN] 1462-8910
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


47. Ngan SY, Fisher R, Burmeister BH, Mackay J, Goldstein D, Kneebone A, Schache D, Joseph D, McKendrick J, Leong T, McClure B, Rischin D: Promising results of a cooperative group phase II trial of preoperative chemoradiation for locally advanced rectal cancer (TROG 9801). Dis Colon Rectum; 2005 Jul;48(7):1389-96
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Promising results of a cooperative group phase II trial of preoperative chemoradiation for locally advanced rectal cancer (TROG 9801).
  • PURPOSE: This article reports the overall survival, failure-free survival, local failure, and late radiation toxicity of a phase II trial of preoperative radiotherapy with continuous infusion 5-fluorouracil for rectal cancer after a minimum 3.5 years of follow-up.
  • METHODS: Eligible patients were those with newly diagnosed localized adenocarcinoma of the rectum, within 12 cm of the anal verge, staged T3-T4 and deemed suitable for curative resection.
  • [MeSH-major] Adenocarcinoma / drug therapy. Adenocarcinoma / radiotherapy. Fluorouracil / therapeutic use. Rectal Neoplasms / drug therapy. Rectal Neoplasms / radiotherapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Combined Modality Therapy. Dose Fractionation. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Radiotherapy Dosage. Survival Rate. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15906126.001).
  • [ISSN] 0012-3706
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
  • [Publication-country] United States
  • [Chemical-registry-number] U3P01618RT / Fluorouracil
  •  go-up   go-down


48. Moraes Rda S, Malafaia O, Telles JE, Trippia MA, Buess GF, Coelho JC: [Transanal endoscopic microsurgery in the treatment of rectal tumors: a prospective study in 50 patients]. Arq Gastroenterol; 2008 Oct-Dec;45(4):268-74
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Transanal endoscopic microsurgery in the treatment of rectal tumors: a prospective study in 50 patients].
  • BACKGROUND: The medical literature accepts local resection as a valuable option in selected cases of rectal tumors.
  • METHODS: From April 2002 to April 2006, 50 patients with rectal tumors were submitted to transanal endoscopic microsurgery, chosen by clinical history and lesion characteristics.
  • The inclusion criteria were: sessile adenomas larger than 3 cm and smaller than 8 cm, not circumferentially distributed; intra epithelial neoplasia of high degree; and rectal carcinoma pT1, and special cases of pT2.
  • All these rectal tumors were submitted to the same surgical act.
  • RESULTS: The final histopathological results reveal 9 adenoma, 26 intra-epithelial neoplasia of high degree, 13 carcinoma (9 pT1-4 pT2) and 2 carcinoid.
  • One patient with low risk carcinoma pT1 presented recurrence 18 months after transanal endoscopic microsurgery and was submitted to curative rectosigmoidectomy.
  • It was proven a residual tumor after local surgery in two patients and the most important complication was one recto-vaginal fistula.
  • CONCLUSION: Today transanal endoscopic microsurgery is chosen as the ideal technique for the treatment of sessile adenomas, intraepithelial neoplasia of high degree and rectal carcinoma pT1.
  • [MeSH-major] Adenoma / surgery. Carcinoma / surgery. Microsurgery / methods. Proctoscopy / methods. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Anal Canal. Follow-Up Studies. Humans. Middle Aged. Neoplasm Recurrence, Local. Neoplasm, Residual. Prospective Studies. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19148353.001).
  • [ISSN] 1678-4219
  • [Journal-full-title] Arquivos de gastroenterologia
  • [ISO-abbreviation] Arq Gastroenterol
  • [Language] por
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


49. Roh YH, Lee HW, Kim MC, Lee KW, Roh MS: Collision tumor of the rectum: a case report of metastatic gastric adenocarcinoma plus primary rectal adenocarcinoma. World J Gastroenterol; 2006 Sep 14;12(34):5569-72
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Collision tumor of the rectum: a case report of metastatic gastric adenocarcinoma plus primary rectal adenocarcinoma.
  • We report here a highly unusual case of a 61-year old man who had a unique tumor that was composed of a metastatic adenocarcinoma from the stomach to the rectum, which harbored a collision tumor of primary rectal adenocarcinoma.
  • The clonalities of the two histologically distinct lesions of the rectal mass were confirmed by immunohistochemical and molecular analysis.
  • [MeSH-major] Adenocarcinoma / pathology. Adenocarcinoma / secondary. Rectal Neoplasms / pathology. Rectal Neoplasms / secondary. Stomach Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mod Pathol. 2000 Feb;13(2):131-9 [10697269.001]
  • [Cites] Mod Pathol. 2001 Jun;14(6):543-8 [11406654.001]
  • [Cites] Diagn Mol Pathol. 2003 Sep;12(3):151-9 [12960697.001]
  • [Cites] J Natl Cancer Inst. 2004 Feb 18;96(4):261-8 [14970275.001]
  • [Cites] Head Neck. 2004 Jul;26(7):637-41 [15229907.001]
  • [Cites] J Pathol. 1999 Jul;188(3):258-62 [10419592.001]
  • [Cites] Am J Clin Pathol. 2004 Jul;122(1):61-9 [15272531.001]
  • [Cites] Am J Surg Pathol. 2004 Nov;28(11):1492-8 [15489653.001]
  • [Cites] Lab Invest. 1986 Oct;55(4):497-504 [2429069.001]
  • [Cites] Dermatology. 1997;194(4):378-9 [9252769.001]
  • [Cites] Pathol Res Pract. 2004;200(5):371-7 [15239345.001]
  • (PMID = 17007003.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC4088248
  •  go-up   go-down


50. Appu S, Lawrentschuk N, Russell JM, Bright NF: Metachronous metastasis to the penis from carcinoma of the rectum. Int J Urol; 2006 May;13(5):659-61
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metachronous metastasis to the penis from carcinoma of the rectum.
  • Furthermore, very few cases exist where primary rectal carcinoma metastasising to the penis has been reported.
  • [MeSH-major] Adenocarcinoma / pathology. Penile Neoplasms / pathology. Penile Neoplasms / secondary. Rectal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16771752.001).
  • [ISSN] 0919-8172
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


51. Cui CY, Li L, Liu LZ: [Value of multislice spiral CT in preoperative staging of rectal carcinoma]. Ai Zheng; 2008 Feb;27(2):196-200
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Value of multislice spiral CT in preoperative staging of rectal carcinoma].
  • BACKGROUND & OBJECTIVE: Preoperative staging is important for optimal therapy planning and prognosis prediction of rectal carcinoma.
  • The role of conventional computed tomography (CT) in preoperative staging of rectal carcinoma is controversial.
  • This study was to evaluate the value of multislice spiral computed tomography (MSCT) in preoperative staging of rectal carcinoma.
  • 2007, 87 patients with pathologically proved rectal cancer underwent preoperative plain and enhanced MSCT.
  • Two radiologists evaluated independently tumor location, size, the depth of tumor invasion into the rectal wall (T), the involvement of regional lymph nodes (N) and the presence of distant metastases (M) on CT images.
  • RESULTS: All the 87 cases of rectal carcinoma were detected clearly by MSCT.
  • CONCLUSION: MSCT is an accurate technique for preoperative staging of rectal carcinoma, which can assess the extension to adjacent tissues and the presence of lymph node and distant metastases exactly.
  • [MeSH-major] Rectal Neoplasms / pathology. Rectal Neoplasms / radiography. Tomography, Spiral Computed / methods
  • [MeSH-minor] Adult. Aged. Female. Humans. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Staging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18279621.001).
  • [Journal-full-title] Ai zheng = Aizheng = Chinese journal of cancer
  • [ISO-abbreviation] Ai Zheng
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


52. Edino ST, Mohammed AZ, Ochicha O: Characteristics of colorectal carcinoma in Kano, Nigeria: an analysis of 50 cases. Niger J Med; 2005 Apr-Jun;14(2):161-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characteristics of colorectal carcinoma in Kano, Nigeria: an analysis of 50 cases.
  • BACKGROUND: Several recent publications have shown a rising incidence with high morbidity and mortality of colorectal cancer amongst blacks.
  • The aim of this study was to determine the epidemiological profile of the colorectal carcinoma in our hospital, a major referral centre in northwestern Nigeria.
  • METHODOLOGY: A retrospective analysis of all histologically proven cases of colorectal carcinoma was performed from January 1999 to December 2002.
  • Carcinoma of the colon occurred in 22 (44%) patients and rectal carcinoma in 28 (56%) patients.
  • Twenty (71.4%) of the 28 rectal cancers were digitally palpable.
  • Adenocarcinoma was the only histologic type, with 15 (30%) cases of the mucinous variety.
  • Any adult with complaints of vague abdominal pain, blood or mucus in the stool or features of haemorrhoids which may herald the onset of colorectal cancer should be adequately investigated with digital rectal examination (DRE) and proctosigmoidoscopy and barium enema where appropriate.
  • [MeSH-major] Adenocarcinoma / epidemiology. Colorectal Neoplasms / epidemiology

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16083239.001).
  • [ISSN] 1115-2613
  • [Journal-full-title] Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria
  • [ISO-abbreviation] Niger J Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Nigeria
  •  go-up   go-down


53. You YN, Wolff BG, Boardman LA, Riegert-Johnson DL, Qin R: Peutz-Jeghers syndrome: a study of long-term surgical morbidity and causes of mortality. Fam Cancer; 2010 Dec;9(4):609-16
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Patients with Peutz-Jeghers syndrome (PJS) require lifelong multidisciplinary care for gastrointestinal polyposis and increased risk of cancer.
  • Patients with a definitive diagnosis of PJS (n = 54) were retrospectively reviewed for disease course and outcome.
  • Two malignancies were found intra-operatively (duodenal and rectal adenocarcinoma).
  • The cause of death was unknown in 4 patients, but was due exclusively to malignancies in all other patients, most commonly due to metastatic gynecologic cancer (5).
  • Given the morbidities associated with repeated operations and the risk for cancer-related mortality in the long-term, efforts should focus on minimizing the need for surgical intervention and optimizing cancer detection, treatment and prevention.

  • Genetic Alliance. consumer health - Peutz Jeghers syndrome.
  • MedlinePlus Health Information. consumer health - Cancer in Children.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Cancer Res. 2008 Feb 15;14(4):1167-71 [18281551.001]
  • [Cites] Gut. 2002 Oct;51 Suppl 5:V21-7 [12221036.001]
  • [Cites] Arch Surg. 1969 Apr;98(4):509-17 [4887290.001]
  • [Cites] J R Soc Med. 2003 Oct;96(10):505-6 [14519733.001]
  • [Cites] Ann Intern Med. 1998 Jun 1;128(11):896-9 [9634427.001]
  • [Cites] Gastrointest Endosc. 2000 Oct;52(4):552-4 [11023581.001]
  • [Cites] Gut. 1989 Nov;30(11):1588-90 [2599445.001]
  • [Cites] Colorectal Dis. 2004 Sep;6(5):332-5 [15335366.001]
  • [Cites] Clin Gastroenterol Hepatol. 2006 Apr;4(4):408-15 [16616343.001]
  • [Cites] Clin Cancer Res. 2006 May 15;12(10):3209-15 [16707622.001]
  • [Cites] Cancer. 1982 Mar 1;49(5):971-83 [7059931.001]
  • [Cites] J Laparoendosc Adv Surg Tech A. 2007 Feb;17(1):140-2 [17362193.001]
  • [Cites] N Engl J Med. 1987 Jun 11;316(24):1511-4 [3587280.001]
  • [Cites] Surg Laparosc Endosc. 1998 Feb;8(1):17-20 [9488564.001]
  • [Cites] Br J Surg. 1990 Mar;77(3):301-2 [2322793.001]
  • [Cites] Arch Surg. 1981 Sep;116(9):1182-4 [7283716.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2004 Aug;39(2):219-20 [15269641.001]
  • [Cites] Clin Cancer Res. 2003 Aug 1;9(8):3065-72 [12912958.001]
  • [Cites] Surg Laparosc Endosc Percutan Tech. 2003 Aug;13(4):280-2 [12960794.001]
  • [Cites] Can J Surg. 1994 Jun;37(3):231-6 [8199943.001]
  • [Cites] Br J Surg. 1995 Oct;82(10):1311-4 [7489151.001]
  • [Cites] Dig Dis Sci. 1983 Nov;28(11):1047-51 [6628153.001]
  • [Cites] Fam Cancer. 2001;1(2):121-5 [14574008.001]
  • [Cites] Am Surg. 1990 May;56(5):331-3 [2334077.001]
  • [Cites] Surg Endosc. 2000 Dec;14(12):1185-7 [11148795.001]
  • [Cites] Physiol Rev. 2009 Jul;89(3):777-98 [19584313.001]
  • [Cites] J Med Genet. 2005 May;42(5):428-35 [15863673.001]
  • [Cites] Am J Surg Pathol. 1987 Oct;11(10):743-9 [3661821.001]
  • [Cites] Hum Mutat. 2005 Oct;26(4):291-7 [16110486.001]
  • [Cites] Gut. 2007 Oct;56(10):1475-6 [17872577.001]
  • [Cites] Dis Colon Rectum. 2003 Jan;46(1):48-50 [12544521.001]
  • [Cites] Gastroenterology. 2000 Dec;119(6):1447-53 [11113065.001]
  • [Cites] Int J Colorectal Dis. 1994;9(4):177-9 [7876718.001]
  • (PMID = 20571886.001).
  • [ISSN] 1573-7292
  • [Journal-full-title] Familial cancer
  • [ISO-abbreviation] Fam. Cancer
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


54. Zhao DB, Gao JD, Bi JJ, Shao YF, Zhao P: [Lymph node metastasis and prognosis in T1 and T2 rectal carcinoma]. Zhonghua Zhong Liu Za Zhi; 2006 Mar;28(3):235-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Lymph node metastasis and prognosis in T1 and T2 rectal carcinoma].
  • OBJECTIVE: To investigate the characteristics of lymph node metastasis and prognosis of T1/T2 rectal carcinoma.
  • METHODS: The clinical data of 241 patients with T1 or T2 rectal carcinoma were retrospectively analyzed.
  • CONCLUSION: Even though lymph node metastasis can be observed either in T1 or T2 rectal carcinoma, histological differentiation is significantly related to the lymph node metastasis.
  • As radical resection achieve better survival than local resection, it should be suggested as the chief treatment for T1/T2 rectal carcinoma.
  • [MeSH-major] Carcinoma, Ductal / surgery. Lymph Nodes / pathology. Rectal Neoplasms / surgery. Rectum / surgery
  • [MeSH-minor] Adenocarcinoma, Mucinous / radiotherapy. Adenocarcinoma, Mucinous / secondary. Adenocarcinoma, Mucinous / surgery. Adult. Aged. Aged, 80 and over. Female. Humans. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Prognosis. Proportional Hazards Models. Radiotherapy, Adjuvant. Retrospective Studies. Survival Rate

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16875615.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


55. Lohsiriwat V, Boonnuch W, Suttinont P: Esophageal metastasis from rectal carcinoma. J Clin Gastroenterol; 2005 Sep;39(8):744
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Esophageal metastasis from rectal carcinoma.
  • [MeSH-major] Adenocarcinoma / complications. Esophageal Neoplasms / secondary. Rectal Neoplasms / pathology
  • [MeSH-minor] Adult. Biopsy. Diagnosis, Differential. Endoscopy, Gastrointestinal. Humans. Male

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16082290.001).
  • [ISSN] 0192-0790
  • [Journal-full-title] Journal of clinical gastroenterology
  • [ISO-abbreviation] J. Clin. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  •  go-up   go-down


56. Kobayashi N, Hata N, Yokoyama S, Shinada T, Shirakabe A, Mizuno K: A case of Takotsubo cardiomyopathy during 5-fluorouracil treatment for rectal adenocarcinoma. J Nippon Med Sch; 2009 Feb;76(1):27-33
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of Takotsubo cardiomyopathy during 5-fluorouracil treatment for rectal adenocarcinoma.
  • Acute heart failure developed during the administration of 5-fluorouracil (5-FU) and levofolinate calcium in a 62-year-old woman who had underwent a Miles operation for rectal adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / drug therapy. Antimetabolites, Antineoplastic / adverse effects. Fluorouracil / adverse effects. Rectal Neoplasms / drug therapy. Takotsubo Cardiomyopathy / chemically induced

  • Genetic Alliance. consumer health - Cardiomyopathy.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19305108.001).
  • [ISSN] 1345-4676
  • [Journal-full-title] Journal of Nippon Medical School = Nippon Ika Daigaku zasshi
  • [ISO-abbreviation] J Nippon Med Sch
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; U3P01618RT / Fluorouracil
  •  go-up   go-down


57. Portaluri M, Bambace S, Perez C, Angone G: A three-dimensional definition of nodal spaces on the basis of CT images showing enlarged nodes for pelvic radiotherapy. Int J Radiat Oncol Biol Phys; 2005 Nov 15;63(4):1101-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS AND MATERIALS: Twenty consecutive patients (16 males, 4 females; mean age, 66 years; range, 43-80 years) with radiologic diagnosis of nodal involvement by histologically proved cervix carcinoma (two), rectum carcinoma (three), prostate carcinoma (four), lymphoma (five), penis carcinoma (one), corpus uteri carcinoma (one), bladder carcinoma (two), cutis tumor (one), and soft-tissue sarcoma (one) were retrospectively reviewed.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Lymphatic Metastasis / radiography. Male. Middle Aged. Pelvis. Penile Neoplasms / radiography. Penile Neoplasms / radiotherapy. Prostatic Neoplasms / radiography. Prostatic Neoplasms / radiotherapy. Rectal Neoplasms / radiography. Rectal Neoplasms / radiotherapy. Retrospective Studies. Tomography, X-Ray Computed. Uterine Neoplasms / radiography. Uterine Neoplasms / radiotherapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15913911.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


58. Perez RO, Habr-Gama A, Nishida Arazawa ST, Rawet V, Coelho Siqueira SA, Kiss DR, Gama-Rodrigues JJ: Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy. Int J Colorectal Dis; 2005 Sep;20(5):434-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy.
  • OBJECTIVE: The objective was to determine the presence and frequency of micrometastasis in lymph nodes of patients with rectal cancer treated by preoperative chemoradiation followed by curative resection.
  • PATIENTS AND METHODS: All 56 patients included were treated with 5-FU and leucovorin plus 5,040 cGy, followed by radical surgery and were diagnosed with stage II distal rectal adenocarcinoma after complete pathological examination (ypT3-4N0M0).
  • There were two cancer-related deaths.
  • CONCLUSION: Patients with rectal cancer treated by preoperative chemoradiation showed a surprisingly low rate of micrometastasis detection (7%), even in high-risk patients (T3 and T4 tumors).
  • The downstaging effect of preoperative chemoradiation therapy may be significant in reducing even micrometastasis detection in low rectal cancer managed by this treatment strategy.
  • [MeSH-major] Adenocarcinoma / secondary. Adenocarcinoma / therapy. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Neoadjuvant Therapy. Rectal Neoplasms / pathology. Rectal Neoplasms / therapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Chemotherapy, Adjuvant. Digestive System Surgical Procedures. Female. Fluorouracil / therapeutic use. Follow-Up Studies. Humans. Immunohistochemistry. Leucovorin / therapeutic use. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Recurrence, Local. Neoplasm Staging. Radiotherapy, Adjuvant. Treatment Outcome. Vitamin B Complex / administration & dosage. Vitamin B Complex / therapeutic use

  • Genetic Alliance. consumer health - Rectal Cancer.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 2002 Oct 15;20(20):4232-41 [12377967.001]
  • [Cites] Surgery. 1993 Apr;113(4):365-72 [7681222.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1987 Jul;13(7):999-1006 [3597163.001]
  • [Cites] J Gastrointest Surg. 2004 Jan;8(1):56-62; discussion 62-3 [14746836.001]
  • [Cites] Gut. 1994 Oct;35(10):1447-8 [7525418.001]
  • [Cites] Clin Cancer Res. 2001 May;7(5):1350-7 [11350905.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1989 Jul;17(1):55-62 [2745208.001]
  • [Cites] J Gastroenterol. 1997 Dec;32(6):758-64 [9430013.001]
  • [Cites] J R Soc Med. 1992 Jul;85(7):386-8 [1378498.001]
  • [Cites] J Clin Gastroenterol. 1994 Oct;19(3):210-3 [7806831.001]
  • [Cites] Lab Invest. 1996 Oct;75(4):611-6 [8874391.001]
  • [Cites] Ann Surg Oncol. 2001 May;8(4):300-4 [11352302.001]
  • [Cites] Clin Cancer Res. 1999 Aug;5(8):2065-8 [10473087.001]
  • [Cites] N Engl J Med. 1990 Feb 8;322(6):352-8 [2300087.001]
  • [Cites] Clin Cancer Res. 2002 Mar;8(3):759-67 [11895906.001]
  • [Cites] Dis Colon Rectum. 1991 Oct;34(10):917-20 [1717210.001]
  • [Cites] J Clin Oncol. 1997 Jan;15(1):246-50 [8996149.001]
  • [Cites] N Engl J Med. 1998 Jul 23;339(4):223-8 [9673300.001]
  • [Cites] Clin Chem. 1996 Sep;42(9):1369-81 [8787692.001]
  • [Cites] Dis Colon Rectum. 1998 Oct;41(10):1244-9 [9788387.001]
  • [Cites] Eur J Cancer. 1995 Jul-Aug;31A(7-8):1333-9 [7577046.001]
  • [Cites] Arch Surg. 2002 Feb;137(2):206-10 [11822961.001]
  • [Cites] Cancer. 1994 Feb 1;73(3):563-9 [7507795.001]
  • [Cites] Eur J Surg. 1996 Aug;162(8):637-42 [8891622.001]
  • [Cites] J Am Coll Surg. 2002 Feb;194(2):131-5; discussion 135-6 [11848629.001]
  • [Cites] J Natl Cancer Inst. 2001 Apr 18;93(8):583-96 [11309435.001]
  • [Cites] Dis Colon Rectum. 1998 Sep;41(9):1087-96 [9749491.001]
  • [Cites] J Pathol. 1994 Feb;172(2):183-7 [7513353.001]
  • [Cites] Ann Surg. 2004 Oct;240(4):711-7; discussion 717-8 [15383798.001]
  • [Cites] Am J Clin Oncol. 1992 Oct;15(5):371-5 [1524036.001]
  • [Cites] Hepatogastroenterology. 2004 Nov-Dec;51(60):1703-7 [15532809.001]
  • (PMID = 15759124.001).
  • [ISSN] 0179-1958
  • [Journal-full-title] International journal of colorectal disease
  • [ISO-abbreviation] Int J Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 12001-76-2 / Vitamin B Complex; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil
  •  go-up   go-down


59. Konski A, Li T, Sigurdson E, Cohen SJ, Small W Jr, Spies S, Yu JQ, Wahl A, Stryker S, Meropol NJ: Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. Int J Radiat Oncol Biol Phys; 2009 May 1;74(1):55-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation.
  • PURPOSE: To correlate changes in 2-deoxy-2-[18F]fluoro-d-glucose (18-FDG) positron emission tomography (PET) (18-FDG-PET) uptake with response and disease-free survival with combined modality neoadjuvant therapy in patients with locally advanced rectal cancer.
  • METHODS AND MATERIALS: Charts were reviewed for consecutive patients with ultrasound-staged T3x to T4Nx or TxN1 rectal adenocarcinoma who underwent preoperative chemoradiation therapy at Fox Chase Cancer Center (FCCC) or Robert H.
  • Lurie Comprehensive Cancer Center of Northwestern University with 18-FDG-PET scanning before and after combined-modality neoadjuvant chemoradiation therapy .
  • CONCLUSIONS: A trend was observed for % SUV decrease and posttreatment SUV predicting pCR in patients with rectal cancer treated with preoperative chemoradiation therapy.
  • Further prospective study with a larger sample size is warranted to better characterize the role of 18-FDG-PET for response prediction in patients with rectal cancer.

  • Genetic Alliance. consumer health - Rectal Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • Hazardous Substances Data Bank. MITOMYCIN C .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dis Colon Rectum. 2000 Jan;43(1):18-24 [10813118.001]
  • [Cites] Ann Nucl Med. 2002 Sep;16(6):409-16 [12416580.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):528-35 [14751524.001]
  • [Cites] Dis Colon Rectum. 2004 Mar;47(3):279-86 [14991488.001]
  • [Cites] J Clin Oncol. 2004 Mar 1;22(5):900-8 [14990646.001]
  • [Cites] J Am Coll Surg. 2004 Jul;199(1):1-7 [15217621.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2004 Jun;31(6):811-9 [14762698.001]
  • [Cites] Ann Surg. 2004 Oct;240(4):711-7; discussion 717-8 [15383798.001]
  • [Cites] Biomed Pharmacother. 2004 Oct;58(8):451-7 [15464875.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1123-8 [15752892.001]
  • [Cites] Eur Radiol. 2005 Aug;15(8):1658-66 [15806369.001]
  • [Cites] Semin Oncol. 2005 Dec;32(6 Suppl 9):S63-7 [16399435.001]
  • [Cites] AJR Am J Roentgenol. 2006 Aug;187(2):W202-8 [16861513.001]
  • [Cites] J Nucl Med. 2006 Aug;47(8):1241-8 [16883000.001]
  • (PMID = 19004571.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA006927-449005; United States / NCI NIH HHS / CA / P30 CA006927-449005
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0W860991D6 / Deoxycytidine; 0Z5B2CJX4D / Fluorodeoxyglucose F18; 50SG953SK6 / Mitomycin; 6804DJ8Z9U / Capecitabine; U3P01618RT / Fluorouracil
  • [Other-IDs] NLM/ NIHMS111700; NLM/ PMC2933375
  •  go-up   go-down


60. Greenberg HL, Lopez L, Butler DF: Peristomal metastatic adenocarcinoma of the rectum. Arch Dermatol; 2006 Oct;142(10):1372-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peristomal metastatic adenocarcinoma of the rectum.
  • [MeSH-major] Adenocarcinoma / diagnosis. Rectal Neoplasms / diagnosis. Skin Neoplasms / diagnosis
  • [MeSH-minor] Adult. Colostomy. Diagnosis, Differential. Female. Humans. Neoplasm Metastasis

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17043208.001).
  • [ISSN] 0003-987X
  • [Journal-full-title] Archives of dermatology
  • [ISO-abbreviation] Arch Dermatol
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  •  go-up   go-down


61. Huguier M, Barrier A, Zacharias T, Valinas R: [Positron emission tomography of gastrointestinal carcinomas]. Bull Acad Natl Med; 2006 Jan;190(1):75-84; discussion 84-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PET had a sensitivity of 67% and a specificity of 100% for metastases in 28 patients with cardio-esophageal carcinoma.
  • Among 70 patients with recurrent or metastatic colorectal carcinoma, eight had signs of local recurrence of rectal carcinoma treated by abdominoperineal resection; PET gave four true-positive, one false-negative, and three false-positive results.
  • PET was better than computed tomography (CT) for the diagnosis of peritoneal metastasis, but its sensitivity was only 58%.
  • PET modified the surgical strategy in two (7%) of 28 patients with cardio-esophageal carcinoma, one (5%) of 22 patients with pancreatic carcinoma, and 22 (33%) of 70 patients with colorectal carcinoma (appropriately in 11 cases, inappropriately in 11 cases).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16878447.001).
  • [ISSN] 0001-4079
  • [Journal-full-title] Bulletin de l'Académie nationale de médecine
  • [ISO-abbreviation] Bull. Acad. Natl. Med.
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


62. Beddy D, Hyland JM, Winter DC, Lim C, White A, Moriarty M, Armstrong J, Fennelly D, Gibbons D, Sheahan K: A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy. Ann Surg Oncol; 2008 Dec;15(12):3471-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
  • BACKGROUND: Locally advanced rectal cancer is frequently treated with neoadjuvant chemoradiotherapy to reduce local recurrence and possibly improve survival.
  • This study assessed tumor regression and its influence on survival in patients with rectal cancer treated with chemoradiotherapy followed by curative surgery.
  • METHODS: One hundred twenty-six patients with locally advanced rectal cancer (T3/T4 or N1/N2) were treated with chemoradiotherapy followed by total mesorectal excision.
  • CONCLUSION: Tumor regression grade measured on a 3-point system predicts outcome after chemoradiotherapy and surgery for locally advanced rectal cancer.
  • [MeSH-major] Adenocarcinoma / mortality. Rectal Neoplasms / mortality
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antimetabolites, Antineoplastic / therapeutic use. Chemotherapy, Adjuvant. Cohort Studies. Combined Modality Therapy. Female. Fluorouracil / therapeutic use. Humans. Male. Middle Aged. Neoadjuvant Therapy. Neoplasm Staging. Preoperative Care. Prognosis. Prospective Studies. Radiotherapy, Adjuvant. Remission Induction. Survival Rate. Treatment Outcome. Young Adult

  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18846402.001).
  • [ISSN] 1534-4681
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; U3P01618RT / Fluorouracil
  •  go-up   go-down


63. Sun Myint A, Mukhopadhyay T, Ramani VS, Perkins K, Snee AJ, Jelley F, Wong H, Lee CD: Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes? Colorectal Dis; 2010 Aug;12 Suppl 2:30-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
  • AIM: Preoperative radiotherapy has been shown to improve local control in advanced rectal carcinoma compared with surgery alone.
  • METHOD: Since October 2004, we have used the new rectal HDR applicator for brachytherapy boost in 68 patients following CRT.
  • [MeSH-major] Brachytherapy / methods. Rectal Neoplasms / radiotherapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Combined Modality Therapy. Dose-Response Relationship, Radiation. Female. Humans. Male. Middle Aged. Neoadjuvant Therapy. Neoplasm Recurrence, Local / prevention & control. Neoplasm Staging. Pilot Projects. Survival Analysis

  • Genetic Alliance. consumer health - Rectal Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20618365.001).
  • [ISSN] 1463-1318
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


64. Yaman E, Coskun U, Benekli M, Sozen S, Yamac D, Buyukberber S, Ozturk B, Kaya AO, Yildiz R, Tezel E: Coexistence of gastrointestinal stromal tumor (GIST) of the rectum and adenocarcinoma of the prostate in a patient with familial GIST. Onkologie; 2008 Dec;31(12):697-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Coexistence of gastrointestinal stromal tumor (GIST) of the rectum and adenocarcinoma of the prostate in a patient with familial GIST.
  • The rectum is a rare location for GIST.
  • Prostate adenocarcinoma is the most common malignancy in geriatric men.
  • Rarely, rectal GIST mimics prostate pathologies.
  • A presumptive diagnosis of primary prostate sarcoma was made based on imaging studies and a trucut biopsy.
  • Removal of the mass compressing both the prostate and the rectum revealed the final diagnosis of synchronous prostate adenocarcinoma and high-grade GIST originating from the rectum.
  • CONCLUSION: According to our knowledge, there are 5 more reported cases of rectal GIST, which were misdiagnosed as prostate malignancy.
  • Rectal GIST may simulate prostate carcinoma clinically, and should always be kept in mind in the differential diagnosis of prostate pathologies.
  • [MeSH-major] Adenocarcinoma / diagnosis. Gastrointestinal Stromal Tumors / congenital. Gastrointestinal Stromal Tumors / diagnosis. Neoplasms, Multiple Primary / diagnosis. Prostatic Neoplasms / diagnosis. Rectal Neoplasms / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Humans. Male. Middle Aged

  • Genetic Alliance. consumer health - Gastrointestinal Stromal Tumors.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2008 S. Karger AG, Basel.
  • (PMID = 19060509.001).
  • [ISSN] 1423-0240
  • [Journal-full-title] Onkologie
  • [ISO-abbreviation] Onkologie
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


65. MERCURY Study Group: Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology; 2007 Apr;243(1):132-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study.
  • PURPOSE: To prospectively evaluate the accuracy of magnetic resonance (MR) imaging in depicting the extramural depth of tumor invasion in patients who have rectal cancer, with histopathologic results as the reference standard.
  • MATERIALS AND METHODS: The Magnetic Resonance Imaging and Rectal Cancer European Equivalence (MERCURY) Study received ethics approval from all participating centers, and all patients gave informed consent.
  • Consecutive patients (n = 679) with adenocarcinoma of the rectum consented to participate.
  • [MeSH-major] Adenocarcinoma / pathology. Magnetic Resonance Imaging / methods. Rectal Neoplasms / pathology

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Radiology. 2008 Feb;246(2):647; author reply 647-8 [18227560.001]
  • (PMID = 17329685.001).
  • [ISSN] 0033-8419
  • [Journal-full-title] Radiology
  • [ISO-abbreviation] Radiology
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


66. Kim DW, Lim SB, Kim DY, Kim TH, Jung KH, Kim DH, Chang HJ, Sohn DK, Hong CW, Choi HS, Jeong SY, Park JG: Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge. Eur J Surg Oncol; 2006 Mar;32(2):162-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge.
  • AIMS: To evaluate whether pre-operative chemo-radiotherapy (CRT) improves the sphincter preservation rate for distal rectal cancers within 3 cm of the anal verge.
  • METHODS: Between January 2001 and December 2004, 49 patients underwent surgery with or without pre-operative CRT for primary rectal adenocarcinoma within 3 cm of the anal verge.
  • RESULTS: Of 49 patients with rectal tumours within 3 cm of the anal verge, 31 underwent pre-operative CRT followed by surgery (CRT group), and 18 underwent surgery alone (non-CRT group).
  • CONCLUSION: We could observe that sphincter preservation was improved in CRT group with statistical significance when compared to non-CRT group in our study patients with rectal cancer within 3 cm of the anal verge.
  • [MeSH-major] Adenocarcinoma / pathology. Adenocarcinoma / therapy. Anal Canal / drug effects. Anal Canal / radiation effects. Neoadjuvant Therapy. Rectal Neoplasms / pathology. Rectal Neoplasms / therapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antimetabolites, Antineoplastic / therapeutic use. Capecitabine. Chemotherapy, Adjuvant. Combined Modality Therapy. Confounding Factors (Epidemiology). Deoxycytidine / analogs & derivatives. Deoxycytidine / therapeutic use. Digestive System Surgical Procedures. Female. Fluorouracil / therapeutic use. Humans. Male. Middle Aged. Neoplasm Staging. Radiotherapy, Adjuvant. Retrospective Studies. Treatment Outcome

  • Genetic Alliance. consumer health - Anal Cancer.
  • Genetic Alliance. consumer health - Rectal Cancer.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16289718.001).
  • [ISSN] 0748-7983
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; U3P01618RT / Fluorouracil
  •  go-up   go-down


67. Koh DM, Brown G, Temple L, Blake H, Raja A, Toomey P, Bett N, Farhat S, Norman AR, Daniels I, Husband JE: Distribution of mesorectal lymph nodes in rectal cancer: in vivo MR imaging compared with histopathological examination. Initial observations. Eur Radiol; 2005 Aug;15(8):1650-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Distribution of mesorectal lymph nodes in rectal cancer: in vivo MR imaging compared with histopathological examination. Initial observations.
  • The aim of this work was to determine the distribution of mesorectal lymph nodes using T2-weighted magnetic resonance (MR) imaging compared with histopathological findings in patients with rectal carcinoma.
  • Sixteen patients with rectal carcinoma undergoing primary surgery without pre-operative neoadjuvant treatment were evaluated using 3-mm axial T2-weighted MR imaging.
  • The position of each visible mesorectal node on imaging was localised by measuring its minimum distance from the mesorectal fascia (d(m)), its minimum distance from the rectal wall (d(r)) and its distance from the distal tumour margin (d(v)).
  • [MeSH-major] Adenocarcinoma / pathology. Lymph Nodes / pathology. Magnetic Resonance Imaging. Rectal Neoplasms / pathology
  • [MeSH-minor] Female. Humans. Male. Middle Aged. Prospective Studies. Rectum / pathology

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJR Am J Roentgenol. 2005 Feb;184(2):531-8 [15671375.001]
  • [Cites] Abdom Imaging. 2000 Sep-Oct;25(5):533-41 [10931993.001]
  • [Cites] Dis Colon Rectum. 2001 Feb;44(2):259-65 [11227944.001]
  • [Cites] Pathol Res Pract. 1991 Dec;187(8):1020-4 [1792183.001]
  • [Cites] Ann Surg Oncol. 2001 Aug;8(7):611-5 [11508624.001]
  • [Cites] Br J Radiol. 1999 Jan;72(853):18-23 [10341684.001]
  • [Cites] Int J Colorectal Dis. 1988 Jun;3(2):127-31 [3045231.001]
  • [Cites] J Am Coll Surg. 1997 Jun;184(6):584-8 [9179114.001]
  • [Cites] Lancet. 2001 Feb 17;357(9255):497-504 [11229667.001]
  • [Cites] Radiology. 2004 Aug;232(2):335-46 [15286305.001]
  • [Cites] Eur Radiol. 2000;10 (4):653-60 [10795550.001]
  • [Cites] Surg Endosc. 1989;3(2):96-9 [2672395.001]
  • [Cites] Eur J Cancer. 2002 May;38(7):911-8 [11978516.001]
  • [Cites] Br J Cancer. 2004 Jul 5;91(1):23-9 [15188013.001]
  • [Cites] Radiology. 1999 Apr;211(1):215-22 [10189474.001]
  • (PMID = 15868124.001).
  • [ISSN] 0938-7994
  • [Journal-full-title] European radiology
  • [ISO-abbreviation] Eur Radiol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


68. Dougherty KR, Khettry U, Stoffel JT, Schoetz DJ: Rectal adenocarcinoma with metachronous metastases to the urethra. Am Surg; 2009 Mar;75(3):265-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rectal adenocarcinoma with metachronous metastases to the urethra.
  • [MeSH-major] Adenocarcinoma / secondary. Neoplasms, Second Primary / secondary. Rectal Neoplasms / pathology. Urethral Neoplasms / secondary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19350868.001).
  • [ISSN] 0003-1348
  • [Journal-full-title] The American surgeon
  • [ISO-abbreviation] Am Surg
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  •  go-up   go-down


69. Karaman K, Bostanci EB, Ercan M, Kurt M, Teke Z, Reyhan E, Akoglu M: Topical Ankaferd application to presacral bleeding due to total mesorectal excision in rectal carcinoma. J Invest Surg; 2010 Jun;23(3):175
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Topical Ankaferd application to presacral bleeding due to total mesorectal excision in rectal carcinoma.
  • [MeSH-major] Blood Loss, Surgical / prevention & control. Plant Extracts / therapeutic use. Rectal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] J Invest Surg. 2009 May-Jun;22(3):201-6 [19466658.001]
  • (PMID = 20590390.001).
  • [ISSN] 1521-0553
  • [Journal-full-title] Journal of investigative surgery : the official journal of the Academy of Surgical Research
  • [ISO-abbreviation] J Invest Surg
  • [Language] eng
  • [Publication-type] Case Reports; Comment; Letter
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Plant Extracts; 0 / ankaferd blood stopper
  •  go-up   go-down


70. Gupta S, Sodhi S, Kaur J, Yamini J: Improvement in electrolyte imbalance in critically ill patient after magnesium supplementation - A case report. Indian J Clin Biochem; 2009 Apr;24(2):208-10
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Hypomagnesaemia is common finding in current medical practice mainly in critically ill, post-operative patients and patients admitted to ICU in tertiary cancer cases.
  • We report a case of 60 year old patient, suffering from rectal carcinoma for a period of one year with confirmed hypokalemia, hypocalcaemia and hyponatremia.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Intern Med. 1992 Jan;152(1):40-5 [1728927.001]
  • [Cites] JAMA. 1990 Jun 13;263(22):3063-4 [2342219.001]
  • [Cites] Am J Kidney Dis. 1994 Nov;24(5):737-52 [7977315.001]
  • [Cites] J Physiol. 1994 May 1;476(3):399-409 [8057249.001]
  • [Cites] Nature. 1993 Dec 9;366(6455):575-80 [8255296.001]
  • [Cites] Intensive Care Med. 1996 Aug;22(8):724-7 [8880238.001]
  • [Cites] Kidney Int. 1997 Nov;52(5):1180-95 [9350641.001]
  • [Cites] Braz J Med Biol Res. 2000 Dec;33(12):1443-8 [11105096.001]
  • [Cites] Physiol Rev. 2001 Jan;81(1):239-297 [11152759.001]
  • [Cites] J Intensive Care Med. 2005 Jan-Feb;20(1):3-17 [15665255.001]
  • (PMID = 23105836.001).
  • [ISSN] 0970-1915
  • [Journal-full-title] Indian journal of clinical biochemistry : IJCB
  • [ISO-abbreviation] Indian J Clin Biochem
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3453216
  • [Keywords] NOTNLM ; Hypocalcaemia / Hypokalemia / Hypomagnesaemia / Hyponatremia
  •  go-up   go-down


71. Jiang SM, Wang RB, Yu JM, Zhu KL, Mu DB, Xu ZF: [Correlation of VEGF and Ki67 expression with sensitivity to neoadjuvant chemoradiation in rectal adenocarcinoma]. Zhonghua Zhong Liu Za Zhi; 2008 Aug;30(8):602-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Correlation of VEGF and Ki67 expression with sensitivity to neoadjuvant chemoradiation in rectal adenocarcinoma].
  • OBJECTIVE: To investigate the correlation of expression of vascular endothelial growth factor (VEGF) and proliferating cell nuclear antigen (Ki67) with sensitivity to neoadjuvant chemoradiation in rectal adenocarcinoma.
  • METHODS: Samples of pretreatment biopsies and the resected specimens after neoadjuvant therapy in 32 patients with rectal adenocarcinoma were collected, and the expression of Ki67 and VEGF were detected by immunohistochemistry using specific antibodies.
  • CONCLUSION: The preliminary results of this study demonstrate that the expression of VEGF and Ki67 in pretreatment biopsy of rectal adenocarcinoma may be used as a biomarker to predict tumor response to neoadjuvant chemoradiation.
  • [MeSH-major] Adenocarcinoma / therapy. Ki-67 Antigen / metabolism. Neoadjuvant Therapy. Rectal Neoplasms / therapy. Vascular Endothelial Growth Factor A / metabolism
  • [MeSH-minor] Adult. Aged. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Biomarkers, Tumor / metabolism. Female. Humans. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Radiotherapy, Conformal. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19102938.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Ki-67 Antigen; 0 / VEGFA protein, human; 0 / Vascular Endothelial Growth Factor A
  •  go-up   go-down


72. Johnson JC, Schmidt CR, Shrubsole MJ, Billheimer DD, Joshi PR, Morrow JD, Heslin MJ, Washington MK, Ness RM, Zheng W, Schwartz DA, Coffey RJ, Beauchamp RD, Merchant NB: Urine PGE-M: A metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia. Clin Gastroenterol Hepatol; 2006 Nov;4(11):1358-65
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Thirteen rectal carcinoma patients were treated with celecoxib and urinary PGE-M was measured before and after treatment.
  • PGE-M levels decreased significantly after celecoxib treatment in patients with rectal cancer (median, 21.7 [IQR, 16.2-29.9] vs 9.14 [IQR, 7.14-13.2], P = .009).
  • [MeSH-major] Colorectal Neoplasms / diagnosis. Prostaglandins / urine
  • [MeSH-minor] Adenoma / diagnosis. Aged. Biomarkers, Tumor. Colonic Polyps / diagnosis. Crohn Disease / diagnosis. Crohn Disease / urine. Cyclooxygenase 2 / metabolism. Female. Humans. Immunohistochemistry. Logistic Models. Male. Middle Aged. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16996805.001).
  • [ISSN] 1542-3565
  • [Journal-full-title] Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • [ISO-abbreviation] Clin. Gastroenterol. Hepatol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA46413; United States / NIDDK NIH HHS / DK / DK48831; United States / NIDDK NIH HHS / DK / T32 DK007673; United States / NIDDK NIH HHS / DK / DK52334; United States / NCI NIH HHS / CA / P50 CA095103; United States / NCI NIH HHS / CA / R01 CA046413; United States / NCI NIH HHS / CA / T32 CA106183; United States / NIGMS NIH HHS / GM / GM15431; United States / NIDDK NIH HHS / DK / DK07673; United States / NIDDK NIH HHS / DK / R01 DK048831; United States / NCI NIH HHS / CA / P01 CA077839; United States / NCI NIH HHS / CA / CA106183; United States / NIGMS NIH HHS / GM / P50 GM015431; United States / NCRR NIH HHS / RR / RR00095; United States / NCI NIH HHS / CA / P30 CA068485; United States / NCRR NIH HHS / RR / M01 RR000095; United States / NCI NIH HHS / CA / CA95103; United States / NIDDK NIH HHS / DK / R01 DK052334; United States / NCI NIH HHS / CA / CA68485; United States / NCI NIH HHS / CA / CA77839; United States / NCI NIH HHS / CA / CA69457
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Prostaglandins; 73303-30-7 / 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid; EC 1.14.99.1 / Cyclooxygenase 2
  •  go-up   go-down


73. Gao F, Li C, Li W, Chen L, Tang Z, Tang W: p53 Gene mutations in sporadic colorectal carcinoma in Guangxi region. Cancer Invest; 2006 Nov;24(7):689-95
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] p53 Gene mutations in sporadic colorectal carcinoma in Guangxi region.
  • To explore the spectrum of p53 gene mutations of sporadic colorectal carcinoma in Guangxi, a Zhuang autonomous region in southern China, we examined exons 2 approximately 11 and exon-intron junctions of p53 gene from 48 patients with sporadic colorectal carcinoma by using single strand conformation polymorphism (SSCP) and DNA direct sequencing.
  • The frequency (47.83 percent) of p53 gene mutations in rectal carcinoma was higher than that (16 percent) in colonic carcinoma (P < 0.025).
  • [MeSH-major] Colonic Neoplasms / genetics. Mutation / genetics. Rectal Neoplasms / genetics. Tumor Suppressor Protein p53 / genetics
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. China. DNA, Neoplasm / genetics. Exons / genetics. Female. Humans. Male. Middle Aged. Polymerase Chain Reaction. Polymorphism, Single-Stranded Conformational

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17118779.001).
  • [ISSN] 0735-7907
  • [Journal-full-title] Cancer investigation
  • [ISO-abbreviation] Cancer Invest.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Neoplasm; 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


74. Haidinger G, Waldhoer T, Hackl M, Vutuc C: Survival of patients with colorectal cancer in Austria by sex, age, and stage. Wien Med Wochenschr; 2006 Oct;156(19-20):549-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Survival of patients with colorectal cancer in Austria by sex, age, and stage.
  • This paper for the first time presents Austrian data on survival of patients, diagnosed from 1998 through 2002, with colon cancer and with rectal cancer.
  • In carcinoma of the colon 5-year relative survival was 66 % in males and 64 % in females.
  • In carcinoma of the rectum 5-year relative survival was 64 % in males and 67 % in females.
  • Compared to the earlier results from the Tyrol (based on patients diagnosed from 1990 through 1994) the 5-year survival of patients with colon cancer increased from 55 % to 66 % in males and from 58 % to 64 % in females.
  • In patients with rectal cancer 5-year survival increased from 44 % to 64 % in males and from 46 % to 67 % in females.
  • [MeSH-minor] Age Factors. Aged. Austria. Early Diagnosis. Female. Humans. Male. Middle Aged. Neoplasm Staging. Sex Factors. Survival Rate

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Cancer. 2005 Oct;41(15):2321-30 [16125930.001]
  • [Cites] Eur J Cancer. 2005 Oct;41(15):2297-303 [16140008.001]
  • [Cites] Wien Klin Wochenschr. 2002 Jun 14;114(10-11):368-76 [12708089.001]
  • [Cites] Wien Klin Wochenschr. 1991;103(10):288-95 [1858377.001]
  • [Cites] Stat Med. 2004 Jan 15;23(1):51-64 [14695639.001]
  • [Cites] Wien Klin Wochenschr. 2004 Oct 30;116(19-20):669-75 [15941076.001]
  • [Cites] Wien Klin Wochenschr. 2005 Feb;117(4):154-71 [15847197.001]
  • [Cites] Ann Oncol. 2003;14 Suppl 5:v61-118 [14684501.001]
  • (PMID = 17103293.001).
  • [ISSN] 0043-5341
  • [Journal-full-title] Wiener medizinische Wochenschrift (1946)
  • [ISO-abbreviation] Wien Med Wochenschr
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Austria
  •  go-up   go-down


75. Yamamoto S, Fukunaga M, Miyajima N, Okuda J, Konishi F, Watanabe M, Japan Society of Laparoscopic Colorectal Surgery: Impact of conversion on surgical outcomes after laparoscopic operation for rectal carcinoma: a retrospective study of 1,073 patients. J Am Coll Surg; 2009 Mar;208(3):383-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Impact of conversion on surgical outcomes after laparoscopic operation for rectal carcinoma: a retrospective study of 1,073 patients.
  • BACKGROUND: In laparoscopic operations for rectal carcinoma, only a few multicenter studies of a large number of patients have examined the impact of conversion on outcomes and determined risk factors for conversion.
  • This study was designed to evaluate short-term outcomes and risk factors for conversion to open operation in laparoscopic operations for rectal carcinoma.
  • STUDY DESIGN: A total of 1,073 patients with carcinoma of the rectum and anus who underwent laparoscopic operations were reviewed retrospectively.
  • Body mass index and the particular laparoscopic procedure are risk factors for conversion, indicating that appropriate patient selection is essential in laparoscopic operations for rectal carcinoma.
  • [MeSH-major] Digestive System Surgical Procedures. Laparoscopy. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Anal Canal / surgery. Body Mass Index. Female. Humans. Intraoperative Complications / classification. Intraoperative Complications / epidemiology. Intraoperative Complications / etiology. Length of Stay. Male. Middle Aged. Multivariate Analysis. Neoplasm Staging. Postoperative Complications / classification. Postoperative Complications / epidemiology. Postoperative Complications / etiology. Postoperative Hemorrhage / epidemiology. Retrospective Studies. Risk Factors. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19318000.001).
  • [ISSN] 1879-1190
  • [Journal-full-title] Journal of the American College of Surgeons
  • [ISO-abbreviation] J. Am. Coll. Surg.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Investigator] Watanabe M; Kokuba Y; Konishi F; Kawamura Y; Miyajima N; Fukunaga M; Kudo S; Tanaka J; Tanigawa N; Okuda J; Nagai H; Otsuka K; Fukunaga Y; Okajima M; Bandou H; Kitano S; Inomata M; Kubo Y; Ichihara T; Hasegawa H; Yamamoto S; Ikoma S; Nishiyama Y; Sugihara K; Yamaguchi S; Sekimoto M; Masaki M; Idani H; Sumiyama Y; Saida Y; Munemoto Y; Maeda K; Hanai K; Kuroyanagi H; Ueda K
  •  go-up   go-down


76. Panis Y: [Laparoscopy and colorectal cancer]. Bull Acad Natl Med; 2007 Oct;191(7):1375-8; discussion 1379
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Laparoscopy and colorectal cancer].
  • [Transliterated title] Laparoscopie et cancer colorectal.
  • Laparoscopy is associated with better postoperative outcome than laparotomy in the treatment of colon cancer, and similar oncologic results.
  • Thus, laparoscopy is now a validated approach to colon cancer management.
  • In contrast, more studies are needed before endorsing the use of laparoscopy to treat rectal carcinoma.
  • [MeSH-minor] Colectomy / methods. Female. Humans. Male. Randomized Controlled Trials as Topic / statistics & numerical data. Rectal Neoplasms / surgery. Treatment Outcome

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18447059.001).
  • [ISSN] 0001-4079
  • [Journal-full-title] Bulletin de l'Académie nationale de médecine
  • [ISO-abbreviation] Bull. Acad. Natl. Med.
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 10
  •  go-up   go-down


77. Taher AN, El-Baradie MM, Nasr AM, Khorshid O, Morsi A, Hamza MR, Mokhtar N, Ezzat S: Locally advanced rectal carcinoma: preoperative radiotherapy versus postoperative chemoradiation, 10-year follow-up results of a randomized clinical study. J Egypt Natl Canc Inst; 2006 Sep;18(3):233-43
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Locally advanced rectal carcinoma: preoperative radiotherapy versus postoperative chemoradiation, 10-year follow-up results of a randomized clinical study.
  • PURPOSE: A prospective study was designed to randomize locally advanced rectal carcinoma patients between either preoperative radiotherapy (+/- postoperative chemotherapy) or postoperative adjuvant chemoradiation.
  • PATIENTS AND METHODS: This is a prospective randomized clinical study including patients with locally advanced low rectal cancer treated at the National Cancer Institute (NCI), Cairo University, during the period from December 1994 to January 1999.
  • Fifty patients with previously untreated rectal cancer were randomized into two groups, Group I: Subjected to surgery followed by radiation therapy (50Gy/5 weeks, 2Gy/fraction, 5 days/week) plus chemotherapy and Group II, subjected to preoperative radiotherapy (46Gy/4.5 weeks, 2Gy/ fraction, 5 days/week) followed by surgery +/- postoperative chemotherapy.
  • [MeSH-major] Carcinoma / mortality. Carcinoma / radiotherapy. Postoperative Care. Preoperative Care. Rectal Neoplasms / mortality. Rectal Neoplasms / radiotherapy

  • MedlinePlus Health Information. consumer health - After Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17671533.001).
  • [ISSN] 1110-0362
  • [Journal-full-title] Journal of the Egyptian National Cancer Institute
  • [ISO-abbreviation] J Egypt Natl Canc Inst
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial
  • [Publication-country] Egypt
  •  go-up   go-down


78. Sciubba DM, Nelson C, Gok B, McGirt MJ, McLoughlin GS, Noggle JC, Wolinsky JP, Witham TF, Bydon A, Gokaslan ZL: Evaluation of factors associated with postoperative infection following sacral tumor resection. J Neurosurg Spine; 2008 Dec;9(6):593-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, extensive soft-tissue resection in close proximity to the rectum may predispose patients to wound complications and infection.
  • Histopathological findings included the following: chordoma in 19 (41%), ependymoma in 5 (11%), rectal adenocarcinoma in 5 (11%), giant cell tumor in 4 (9%), and other in 13 (28%).
  • CONCLUSIONS: Patients undergoing sacral tumor surgery may be at greater risk for developing wound complications due to the extensive soft-tissue resections often required, especially with the increased potential for contamination from the neighboring rectum.

  • MedlinePlus Health Information. consumer health - Cancer in Children.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19035755.001).
  • [ISSN] 1547-5654
  • [Journal-full-title] Journal of neurosurgery. Spine
  • [ISO-abbreviation] J Neurosurg Spine
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


79. Lemmens V, van Steenbergen L, Janssen-Heijnen M, Martijn H, Rutten H, Coebergh JW: Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival. Acta Oncol; 2010 Aug;49(6):784-96
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival.
  • OBJECTIVE: In the Netherlands over 11 200 patients are yearly diagnosed with colorectal cancer (CRC), of who about 4 700 are expected to die of the disease ultimately.
  • PATIENTS: The 26 826 cases of primary CRC (C18.0-C20.9) diagnosed between 1975 and 2007 in the Dutch population-based Eindhoven Cancer Registry area were included.
  • RESULTS: The age-standardised incidence of colon carcinoma kept increasing, most markedly in males (up to 39 patients per 100 000 inhabitants) and for tumours of the colon ascendens (subsite-specific incidence doubled).
  • The incidence of rectal carcinoma remained stable.
  • The proportion of patients diagnosed with distant metastases increased up to 25% for colon carcinoma (p<0.0001).
  • Recently, the use of adjuvant chemotherapy seemed to level off among patients with stage III colon carcinoma, but the use of neo-adjuvant chemoradiation clearly increased among patients with stage II/III rectal cancer (p<0.0001).
  • Five-year relative survival of colon cancer improved from 51% in 1975-1984 to 58% in 2000-2004, for rectal cancer it improved from 44 to 59%.
  • Two-year relative survival of colon cancer in 2005-2006 was 69%, and 77% for rectal cancer.
  • CONCLUSIONS: The changes in management of rectal cancer led to a superior increase in survival of these patients compared to patients with colon cancer, even surpassing the latter.
  • [MeSH-major] Colonic Neoplasms / epidemiology. Rectal Neoplasms / epidemiology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Incidence. Male. Middle Aged. Mortality / trends. Neoplasm Staging. Netherlands / epidemiology. Prevalence. Registries. Survival Analysis

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • Genetic Alliance. consumer health - Rectal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20429731.001).
  • [ISSN] 1651-226X
  • [Journal-full-title] Acta oncologica (Stockholm, Sweden)
  • [ISO-abbreviation] Acta Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


80. Friedland S, Benaron D, Maxim P, Parachikov I, Soetikno R: Absence of ischemia in telangiectasias of chronic radiation proctopathy. Endoscopy; 2006 May;38(5):488-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We therefore hypothesized that the ischemia theory is incorrect and that rectal capillary oxygen saturation is normal in patients with telangiectasias of chronic radiation proctopathy.
  • We prospectively studied 20 patients who had typical findings of multiple rectal telangiectasias, 1 - 20 years after undergoing external-beam irradiation for prostate or rectal carcinoma.
  • We measured and compared the mucosal capillary oxygen saturations in the affected areas of the distal rectum and in endoscopically normal areas in the rectosigmoid colon.
  • The mean mucosal hemoglobin oxygen saturation was actually slightly higher in the affected areas of the rectum than in the uninvolved rectosigmoid colon (73 % vs. 69 %, P < 0.01).
  • This finding may explain why endoscopic treatment of this disorder, in which large areas of the mucosa are coagulated with argon plasma or other treatment modalities that cause widespread ulceration, does not typically result in complications from poor wound healing.
  • [MeSH-major] Colonoscopes. Colonoscopy / methods. Gastrointestinal Hemorrhage / diagnosis. Gastrointestinal Hemorrhage / etiology. Ischemia / diagnosis. Ischemia / etiology. Radiotherapy / adverse effects. Rectal Diseases / diagnosis. Rectal Diseases / etiology. Telangiectasis / diagnosis. Telangiectasis / etiology


81. Daniel WJ: Anorectal pain, bleeding and lumps. Aust Fam Physician; 2010 Jun;39(6):376-81
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The patient presenting with anal pain, anal lump or rectal bleeding is a common occurrence in the general practice setting and the combination of symptoms usually gives an indication of the most likely diagnosis.
  • However, careful examination including digital rectal examination is always required.
  • OBJECTIVE: This article discusses three common anorectal conditions: perianal haematoma, haemorrhoids and anal fissure, and briefly discusses the less common, but not to be missed conditions: anal carcinoma and low rectal carcinoma.
  • Anal cancer has similar presentation to haemorrhoids and carcinoma of distal rectum can initially present with a haemorrhoid, so the possibility of anorectal cancer should be considered in any patient presenting with haemorrhoids, tenesmus and change in bowel habit.
  • [MeSH-major] Pain / diagnosis. Rectal Diseases / physiopathology
  • [MeSH-minor] Diagnosis, Differential. Hemorrhage / etiology. Humans

  • MedlinePlus Health Information. consumer health - Pain.
  • MedlinePlus Health Information. consumer health - Rectal Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20628675.001).
  • [ISSN] 0300-8495
  • [Journal-full-title] Australian family physician
  • [ISO-abbreviation] Aust Fam Physician
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


82. Leonardi MC, Zampino MG, Luca F, Jereczek-Fossa BA, Petazzi E, Tatani B, Lazzari R, Biffi R, Lorizzo K, Magni E, Scanniffio D, Orsi F, Bonomo G, Petralia G, Trovato C, Crosta C, Andreoni B, Orecchia R: Pre-operative radiochemotherapy with raltitrexed for resectable locally-advanced rectal cancer: a phase II study. Anticancer Res; 2006 May-Jun;26(3B):2419-23
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pre-operative radiochemotherapy with raltitrexed for resectable locally-advanced rectal cancer: a phase II study.
  • BACKGROUND: The aim of the study was to evaluate the response to and toxicity of pre-operative radiochemotherapy containing raltitrexed (Tomudex) for resectable rectal adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / drug therapy. Adenocarcinoma / radiotherapy. Antimetabolites, Antineoplastic / therapeutic use. Quinazolines / therapeutic use. Rectal Neoplasms / drug therapy. Rectal Neoplasms / radiotherapy. Thiophenes / therapeutic use

  • Genetic Alliance. consumer health - Rectal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16821626.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Quinazolines; 0 / Thiophenes; FCB9EGG971 / raltitrexed
  •  go-up   go-down


83. Rengan R, Paty P, Wong WD, Guillem J, Weiser M, Temple L, Saltz L, Minsky BD: Distal cT2N0 rectal cancer: is there an alternative to abdominoperineal resection? J Clin Oncol; 2005 Aug 1;23(22):4905-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Distal cT2N0 rectal cancer: is there an alternative to abdominoperineal resection?
  • PURPOSE: Patients with cT2N0 distal rectal cancer do not require adjuvant therapy.
  • The purpose of this trial is to determine whether preoperative external-beam radiation therapy can increase the rate of sphincter preservation for patients with distal cT2N0 adenocarcinoma of the rectum.
  • PATIENTS AND METHODS: Between April 1988 and October 2003, 27 patients with distal rectal adenocarcinoma staged T2 by clinical and/or endorectal ultrasound who were judged by the operating surgeon to require an APR were treated with preoperative pelvic radiation alone (50.4 Gy).
  • Using the Memorial Sloan-Kettering Cancer Center sphincter function score, 54% of those undergoing a sphincter-sparing procedure had good/excellent bowel function at 12 to 24 months after surgery, and 77% had good/excellent function at 24 to 36 months after surgery.
  • CONCLUSION: Our data suggest that for patients with cT2N0 distal rectal cancer who require an APR, preoperative pelvic radiation improves sphincter preservation without an apparent compromise in local control or survival.
  • [MeSH-major] Adenocarcinoma / radiotherapy. Adenocarcinoma / surgery. Anal Canal / surgery. Rectal Neoplasms / radiotherapy. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Colostomy. Disease-Free Survival. Female. Humans. Male. Middle Aged. Neoadjuvant Therapy. Neoplasm Staging. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16051945.001).
  • [ISSN] 0732-183X
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


84. Ketata S, Boulaire JL, Soulimane B, Bargain A: Metachronous metastasis to the penis from a rectal adenocarcinoma. Clin Colorectal Cancer; 2007 Sep;6(9):657-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metachronous metastasis to the penis from a rectal adenocarcinoma.
  • We report the case of a 59-year-old patient with 2 penile metastases from a rectal adenocarcinoma, which was discovered 26 years after abdominoperineal resection.
  • All previously reported cases of penile metastasis from the rectum are reviewed.
  • [MeSH-major] Adenocarcinoma / secondary. Penile Neoplasms / secondary. Rectal Neoplasms / pathology

  • Hazardous Substances Data Bank. CETUXIMAB .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17945039.001).
  • [ISSN] 1533-0028
  • [Journal-full-title] Clinical colorectal cancer
  • [ISO-abbreviation] Clin Colorectal Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 7673326042 / irinotecan; PQX0D8J21J / Cetuximab; XT3Z54Z28A / Camptothecin
  • [Number-of-references] 18
  •  go-up   go-down


85. Mojica-Manosa P, Rigual N, Tan D, Sullivan M: An unusual case of a metastatic adenocarcinoma of the rectum to the mandible: a case report and review of the literature. J Oral Maxillofac Surg; 2006 Sep;64(9):1436-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An unusual case of a metastatic adenocarcinoma of the rectum to the mandible: a case report and review of the literature.
  • [MeSH-major] Adenocarcinoma / secondary. Mandibular Neoplasms / secondary. Rectal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16916682.001).
  • [ISSN] 0278-2391
  • [Journal-full-title] Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
  • [ISO-abbreviation] J. Oral Maxillofac. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 13
  •  go-up   go-down


86. Kim JS, Hur H, Min BS, Kim H, Sohn SK, Cho CH, Kim NK: Intestinal endometriosis mimicking carcinoma of rectum and sigmoid colon: a report of five cases. Yonsei Med J; 2009 Oct 31;50(5):732-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intestinal endometriosis mimicking carcinoma of rectum and sigmoid colon: a report of five cases.
  • Among women with intestinal endometriosis, the sigmoid colon and rectum are the most commonly involved areas.
  • Sometimes, the differential diagnosis of colorectal endometriosis from carcinoma of the colon and rectum is difficult due to similar colonoscopic and radiologic findings.
  • From October 2002 to September 2007, we performed five operations with curative intent for rectal and sigmoid colon cancer that revealed intestinal endometriosis.
  • Colonoscopic and radiologic findings were suggestive of carcinoma of rectum and sigmoid colon, such as rectal cancer, sigmoid colon cancer and gastrointestinal stromal tumor (GIST).
  • [MeSH-major] Carcinoma / diagnosis. Endometriosis / diagnosis. Rectal Neoplasms / diagnosis. Sigmoid Neoplasms / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Middle Aged

  • Genetic Alliance. consumer health - Endometriosis.
  • MedlinePlus Health Information. consumer health - Endometriosis.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dig Dis Sci. 2001 Sep;46(9):1963-7 [11575450.001]
  • [Cites] Obstet Gynecol Clin North Am. 2003 Mar;30(1):133-50 [12699262.001]
  • [Cites] Curr Opin Obstet Gynecol. 2003 Dec;15(6):519-22 [14624220.001]
  • [Cites] BMC Gastroenterol. 2003 Aug 7;3:18 [12906714.001]
  • [Cites] Curr Opin Obstet Gynecol. 2005 Aug;17(4):399-402 [15976546.001]
  • [Cites] N Engl J Med. 1993 Jun 17;328(24):1759-69 [8110213.001]
  • [Cites] Gastroenterol Clin North Am. 1994 Mar;23(1):21-52 [8132299.001]
  • [Cites] Hum Pathol. 1994 Oct;25(10):1030-4 [7927307.001]
  • [Cites] Lancet. 2004 Nov 13-19;364(9447):1789-99 [15541453.001]
  • [Cites] Am J Surg. 1984 Nov;148(5):660-7 [6496859.001]
  • (PMID = 19881983.001).
  • [ISSN] 1976-2437
  • [Journal-full-title] Yonsei medical journal
  • [ISO-abbreviation] Yonsei Med. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2768254
  • [Keywords] NOTNLM ; Intestinal endometriosis / colorectal neoplasm / endometriosis
  •  go-up   go-down


87. Peruzzi S, Gorrini C, Piccolo G, Calderaro A, Dettori G, Chezzi C: Human intestinal spirochaetosis in Parma: a focus on a selected population during 2002-2005. Acta Biomed; 2007 Aug;78(2):128-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Symptoms of the infection, even if not specific, are long standing diarrhoea, abdominal pain, meteorism and rectal bleeding and sometimes they can suggest the clinical suspect of inflammatory bowel diseases or rectal carcinoma.
  • The diagnosis of HIS was performed by isolation and a molecular assay based on 16S rDNA restriction fragment length polymorphism (RFLP)-polymerase chain reaction (PCR).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17933280.001).
  • [ISSN] 0392-4203
  • [Journal-full-title] Acta bio-medica : Atenei Parmensis
  • [ISO-abbreviation] Acta Biomed
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / DNA, Bacterial
  •  go-up   go-down


88. Matthiessen P, Henriksson M, Hallböök O, Grunditz E, Norén B, Arbman G: Increase of serum C-reactive protein is an early indicator of subsequent symptomatic anastomotic leakage after anterior resection. Colorectal Dis; 2008 Jan;10(1):75-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHOD: Thirty-three patients who underwent anterior resection for rectal carcinoma (n = 32) and severe dysplasia (n = 1), were monitored daily by serum C-reactive protein (CRP) and white blood cell count (WBC) estimations until discharge from hospital.
  • [MeSH-major] C-Reactive Protein / analysis. Colectomy / adverse effects. Rectal Fistula / etiology. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Anastomosis, Surgical / adverse effects. Anastomosis, Surgical / methods. Biomarkers, Tumor / blood. Biopsy, Needle. Chi-Square Distribution. Female. Humans. Immunohistochemistry. Male. Middle Aged. Neoplasm Staging. Postoperative Complications / diagnosis. Probability. Prognosis. Prospective Studies. Risk Assessment. Sensitivity and Specificity. Statistics, Nonparametric. Survival Analysis

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17666099.001).
  • [ISSN] 1463-1318
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 9007-41-4 / C-Reactive Protein
  •  go-up   go-down


89. Gupta PJ: Rectal cancer presenting as ischio-rectal abscess and Fournier's gangrene--a case report. Eur Rev Med Pharmacol Sci; 2010 Feb;14(2):139-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rectal cancer presenting as ischio-rectal abscess and Fournier's gangrene--a case report.
  • We report a case of adenocarcinoma of the rectum where the patient presented with extensive ischio-rectal abscess with Fournier's gangrene.
  • [MeSH-major] Abscess / etiology. Fournier Gangrene / etiology. Rectal Diseases / etiology. Rectal Neoplasms / complications

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - Abscess.
  • MedlinePlus Health Information. consumer health - Rectal Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20329573.001).
  • [ISSN] 1128-3602
  • [Journal-full-title] European review for medical and pharmacological sciences
  • [ISO-abbreviation] Eur Rev Med Pharmacol Sci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


90. Masljankov S, Jaramov N: [Analysis of oncologic results and quality of life after radical treatment of rectum carcinoma in Specialized Oncological Hospital of Veliko Tarnovo]. Khirurgiia (Sofiia); 2009;(4-5):10-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Analysis of oncologic results and quality of life after radical treatment of rectum carcinoma in Specialized Oncological Hospital of Veliko Tarnovo].
  • INTRODUCTION: Rectum carcinoma is an increasing problem with a great variety of possible operative decisions.
  • The aim of this study is to present and analyze the oncologic and initial quality of life data of operated with rectum carcinoma in Specialized Oncological Hospital of Veliko Tarnovo.
  • CONCLUSION: We have better onologic and functional result in early stages and at higher localization of rectum carcinoma disease.
  • [MeSH-major] Carcinoma / surgery. Quality of Life. Rectal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20506798.001).
  • [ISSN] 0450-2167
  • [Journal-full-title] Khirurgii︠a︡
  • [ISO-abbreviation] Khirurgiia (Sofiia)
  • [Language] bul
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Bulgaria
  •  go-up   go-down


91. Park YA, Sohn SK, Seong J, Baik SH, Lee KY, Kim NK, Cho CW: Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer. J Surg Oncol; 2006 Feb 1;93(2):145-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.
  • BACKGROUND AND OBJECTIVES: Recent data suggest that good responders to preoperative chemoradiation (CRT) have a favorable prognosis in rectal cancer patients.
  • The aim of this study was to investigate the predictive value of serum carcinoembryonic antigen (CEA) levels for the tumor response to preoperative CRT in rectal cancer patients.
  • METHODS: The study comprised 141 rectal adenocarcinoma patients who underwent preoperative radiotherapy with 5-fluorouracil (FU) based chemotherapy, followed by radical surgery.
  • The outcome parameters were cancer-specific survival and disease-free survival.
  • GR showed better cancer-specific survival (P = 0.028) and disease-free survival rates (P = 0.011) than PR.
  • Therefore, pre-CRT serum CEA levels provide useful information about tumor response to preoperative CRT in rectal cancer patients.
  • [MeSH-major] Adenocarcinoma / blood. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Biomarkers, Tumor / blood. Carcinoembryonic Antigen / blood. Rectal Neoplasms / blood

  • Genetic Alliance. consumer health - Rectal Cancer.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2006 Wiley-Liss, Inc.
  • (PMID = 16425302.001).
  • [ISSN] 0022-4790
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Carcinoembryonic Antigen; U3P01618RT / Fluorouracil
  •  go-up   go-down


92. Giridharan S, Vakkalanka B, Anwar MS, Geh JI, Glaholm J, Churn M, Adab F, Grieve R, McConkey C, Hartley A: Multicentre prospective audit of surgical outcomes and acute complications following short course pre-operative radiotherapy for resectable rectal cancer. Colorectal Dis; 2005 Jan;7(1):43-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multicentre prospective audit of surgical outcomes and acute complications following short course pre-operative radiotherapy for resectable rectal cancer.
  • BACKGROUND: The addition of short course pre-operative radiotherapy to total mesorectal excision reduces local recurrence in resectable adenocarcinoma of the rectum.
  • METHODS: One hundred and seven patients who received short course pre-operative radiotherapy in four cancer centres between 1 October 2001 and 30 September 2002 were included.
  • [MeSH-major] Adenocarcinoma / radiotherapy. Adenocarcinoma / surgery. Postoperative Complications. Rectal Neoplasms / radiotherapy. Rectal Neoplasms / surgery
  • [MeSH-minor] Acute Disease. Age Factors. Dose Fractionation. Female. Humans. Male. Medical Audit. Neoplasm Staging. Prospective Studies. Radiotherapy, Adjuvant / methods. Risk Factors. Time Factors. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - After Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15606583.001).
  • [ISSN] 1462-8910
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] England
  •  go-up   go-down


93. Tomita H, Kawamoto R: [Case of rectal carcinoma discovered after extracting a single brain metastasis]. Nihon Ronen Igakkai Zasshi; 2007 Jan;44(1):122-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Case of rectal carcinoma discovered after extracting a single brain metastasis].
  • Metastatic carcinoma was suspected on histological examination, but the primary cancer was not able to be detected by a whole body examination, except for colonoscopy, which was refused by her family.
  • Rectal cancer was discovered by colonoscopy and she underwent Hartman's procedure.
  • Histological examination revealed poorly differentiated adenocarcinoma similar to resected brain tumor.
  • The final solitary diagnosis was metastatic carcinoma from primary rectal cancer.
  • Solitary brain metastasis from colon cancer is extremely rare, however, we should consider the possibility in cancers of the digestive tract.
  • [MeSH-major] Adenocarcinoma / secondary. Brain Neoplasms / secondary. Rectal Neoplasms / diagnosis. Rectal Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17337865.001).
  • [ISSN] 0300-9173
  • [Journal-full-title] Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics
  • [ISO-abbreviation] Nihon Ronen Igakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 13
  •  go-up   go-down


94. Ishibashi H, Ohta T, Sugimoto I, Kawanishi J, Yamada T, Ishiguchi T, Io A: Successful treatment of an aorto-ileal-conduit fistula with an endovascular stent graft: report of a case. Surg Today; 2007;37(4):305-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • He had previously undergone a total pelvic exenteration with ileal conduit construction of the ureters due to rectal carcinoma.

  • MedlinePlus Health Information. consumer health - Ureteral Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Endovasc Ther. 2000 Jun;7(3):240-4 [10883963.001]
  • [Cites] Urology. 1998 Oct;52(4):720-2 [9763104.001]
  • [Cites] Respiration. 2001;68(5):537-9 [11694820.001]
  • [Cites] J Vasc Surg. 1999 Mar;29(3):557-60 [10069922.001]
  • [Cites] AJR Am J Roentgenol. 1994 Apr;162(4):873-8 [8141010.001]
  • [Cites] Eur J Vasc Endovasc Surg. 1999 Jan;17 (1):89-90 [10071625.001]
  • [Cites] J Endovasc Ther. 2005 Jun;12 (3):411-3 [15943520.001]
  • [Cites] Ann Vasc Surg. 2005 Jan;19(1):94-8 [15714375.001]
  • [Cites] Urology. 1996 Sep;48(3):481-9 [8804509.001]
  • [Cites] Urol Int. 2003;71(3):333-5 [14512661.001]
  • [Cites] J Vasc Interv Radiol. 1990 Nov;1(1):69-77; discussion 77-9 [2134038.001]
  • (PMID = 17387562.001).
  • [ISSN] 0941-1291
  • [Journal-full-title] Surgery today
  • [ISO-abbreviation] Surg. Today
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


95. Petrina A, Badolato M, Covarelli P, Boselli C, Noya G: [Colorectal cancer in the elderly: which surgical approach?]. G Chir; 2010 Oct;31(10):443-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Colorectal cancer in the elderly: which surgical approach?].
  • [Transliterated title] Carcinoma colo-rettale nell'anziano: quale approccio chirurgico?
  • Single-operator case studies of 135 patients undergoing surgery for colon rectal carcinoma (CRC) between June 2004 and April 2008 in our Institute.

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20939952.001).
  • [ISSN] 0391-9005
  • [Journal-full-title] Il Giornale di chirurgia
  • [ISO-abbreviation] G Chir
  • [Language] ita
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


96. Chessin DB, Enker W, Cohen AM, Paty PB, Weiser MR, Saltz L, Minsky BD, Wong WD, Guillem JG: Complications after preoperative combined modality therapy and radical resection of locally advanced rectal cancer: a 14-year experience from a specialty service. J Am Coll Surg; 2005 Jun;200(6):876-82; discussion 882-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Complications after preoperative combined modality therapy and radical resection of locally advanced rectal cancer: a 14-year experience from a specialty service.
  • BACKGROUND: Preoperative combined modality therapy followed by total mesorectal excision has emerged as the optimal treatment paradigm for locally advanced rectal cancer (T3 to 4, N1, or both).
  • STUDY DESIGN: The study group consisted of 297 consecutive patients with locally advanced rectal adenocarcinoma treated with preoperative combined modality therapy (radiation: 5,040 cGy; chemotherapy: 5-FU-based) and then operation.
  • A policy of selective fecal diversion after preoperative combined modality therapy and total mesorectal excision for locally advanced rectal cancer can achieve low rates of pelvic sepsis, but may lead to an increased incidence of small bowel obstruction.
  • [MeSH-major] Adenocarcinoma / therapy. Postoperative Complications. Preoperative Care. Rectal Neoplasms / therapy

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - After Surgery.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15922198.001).
  • [ISSN] 1072-7515
  • [Journal-full-title] Journal of the American College of Surgeons
  • [ISO-abbreviation] J. Am. Coll. Surg.
  • [Language] eng
  • [Grant] United States / PHS HHS / / R01 82534-01
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


97. Pramateftakis MG: Optimizing colonic cancer surgery: high ligation and complete mesocolic excision during right hemicolectomy. Tech Coloproctol; 2010 Nov;14 Suppl 1:S49-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Optimizing colonic cancer surgery: high ligation and complete mesocolic excision during right hemicolectomy.
  • The principles of CME and high ligation have been applied by us during colonic resections for cancer.
  • One patient developed a metachronous rectal carcinoma 28 months after his surgery, for which he underwent an abdoperineal resection.
  • It is important to remember that colon cancer treatment today is multimodal and that the improvement in patients' survival in the last decades is surely linked with the improvement in chemotherapy and the advances in the agents used.
  • However, optimal surgery is with no doubt an important element of good oncological outcome, as the experience with rectal cancer treatment has taught us.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Oncol. 2009;48(8):1152-6 [19863223.001]
  • [Cites] Am J Surg. 2007 Sep;194(3):349-54 [17693281.001]
  • [Cites] Colorectal Dis. 2009 May;11(4):354-64; discussion 364-5 [19016817.001]
  • [Cites] J R Soc Med. 1988 Sep;81(9):503-8 [3184105.001]
  • [Cites] Ann Surg. 2006 Oct;244(4):602-10 [16998369.001]
  • (PMID = 20697925.001).
  • [ISSN] 1128-045X
  • [Journal-full-title] Techniques in coloproctology
  • [ISO-abbreviation] Tech Coloproctol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


98. Ishigami S, Kato K, Baba K, Onohara S, Hatanaka S, Aridome K, Okumura H, Matsumoto M, Natsugoe S, Aikou T: [A case of advanced rectal carcinoma, preoperative chemo-radiation therapy leading to histological complete response]. Gan To Kagaku Ryoho; 2006 Sep;33(9):1345-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of advanced rectal carcinoma, preoperative chemo-radiation therapy leading to histological complete response].
  • Perforative rectal cancer was diagnosed, and an emergency laparotomy was done.
  • Preoperatively rectal cancer was assessed to invade the sacral bone and prostate.
  • Once complete regression of the rectal cancer by chemo-radiation therapy has been achieved, relapse of the tumor was reported to be rare.
  • Preoperative chemo-radiation therapy is an effective tool to control the advanced rectal cancer.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Pelvic Exenteration. Preoperative Care. Rectal Neoplasms / drug therapy. Rectal Neoplasms / radiotherapy. Rectum / surgery

  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16969039.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] Q20Q21Q62J / Cisplatin; U3P01618RT / Fluorouracil; CF regimen
  •  go-up   go-down


99. Wang H, Wei XZ, Fu CG, Zhao RH, Cao FA: Patterns of lymph node metastasis are different in colon and rectal carcinomas. World J Gastroenterol; 2010 Nov 14;16(42):5375-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Patterns of lymph node metastasis are different in colon and rectal carcinomas.
  • AIM: To describe patterns of lymph node metastasis in invasive colon and rectal carcinomas.
  • METHODS: Clinical data of 2340 patients with colorectal carcinoma (stage I to III) who received radical resection, was retrospectively reviewed.
  • Of the 2340 patients, 1314 patients suffered from rectal carcinoma and 1026 from colon carcinoma.
  • Patients with rectal cancer who received neoadjuvant chemoradiation therapy were excluded.
  • RESULTS: Lymph node retrieval in the rectal carcinoma group was significantly lower than that in the colon carcinoma group (P < 0.001), while positive lymph node retrieval in the rectal carcinoma group was significantly higher than that in the colon carcinoma group (P < 0.001).
  • The proportion of lymph node positive (N+) cases was higher (patients with one or more positive lymph nodes) in the rectal carcinoma group (P = 0.004).
  • In addition, the lymph node ratio (the ratio of number of positive lymph nodes over the number of lymph nodes examined) of stage III cases in the rectal carcinoma group was significantly higher than that in the colon carcinoma group (P < 0.001).
  • CONCLUSION: Rectal carcinomas seem more prone to metastasize to the lymph nodes than colon carcinomas, which may be of potential clinical significance.
  • [MeSH-major] Colonic Neoplasms / pathology. Lymphatic Metastasis / pathology. Rectal Neoplasms / pathology
  • [MeSH-minor] Aged. Female. Humans. Lymph Node Excision. Lymph Nodes / pathology. Male. Middle Aged. Neoplasm Staging. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Surg. 2002 Oct;236(4):416-21; discussion 421 [12368669.001]
  • [Cites] Dis Colon Rectum. 2002 Feb;45(2):200-6 [11852333.001]
  • [Cites] Cancer. 1998 Aug 15;83(4):666-72 [9708929.001]
  • [Cites] Arch Surg. 1998 Aug;133(8):894-9 [9711965.001]
  • [Cites] J Gastrointest Surg. 2004 Dec;8(8):1032-9; discussion 1039-40 [15585391.001]
  • [Cites] Clin Gastroenterol Hepatol. 2006 Dec;4(12):1522-7 [16979956.001]
  • [Cites] J Gastrointest Surg. 2007 May;11(5):660-5 [17468927.001]
  • [Cites] World J Surg. 2007 Jul;31(7):1485-90 [17510767.001]
  • [Cites] Ann Surg Oncol. 2007 Aug;14(8):2257-62 [17520316.001]
  • [Cites] World J Gastroenterol. 2008 Aug 21;14(31):4903-8 [18756598.001]
  • [Cites] Ann Surg Oncol. 2008 Oct;15(10):2668-76 [18618181.001]
  • [Cites] Dis Colon Rectum. 2009 Apr;52(4):549-57 [19404052.001]
  • [Cites] Ann Surg. 2008 Dec;248(6):968-78 [19092341.001]
  • [Cites] Br J Cancer. 2009 May 19;100(10):1530-3 [19401684.001]
  • [Cites] Dis Colon Rectum. 2009 Jul;52(7):1244-50 [19571700.001]
  • [Cites] Dis Colon Rectum. 2009 Dec;52(12):1941-8 [19934913.001]
  • [Cites] BMC Cancer. 2010;10:267 [20529352.001]
  • [Cites] BMC Gastroenterol. 2010;10:61 [20550703.001]
  • [Cites] J Clin Oncol. 2004 May 15;22(10):1785-96 [15067027.001]
  • [Cites] J Natl Cancer Inst. 2001 Apr 18;93(8):583-96 [11309435.001]
  • [CommentIn] World J Gastroenterol. 2011 Aug 7;17(29):3465-6 [21876640.001]
  • (PMID = 21072903.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC2980689
  •  go-up   go-down






Advertisement